腎泌尿器外科学分野

553  件  
※ 登録方法の違いにより重複して表示されている場合があります。

  1. Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima, Hiroyuki Sato, Akihiro Hirakawa, Yasuhisa Fujii: Restricted mean survival time comparison of olaparib plus abiraterone versus talazoparib plus enzalutamide in first-line metastatic castration-resistant prostate cancer: indirect analyses of propel and talapro-2. Int Urol Nephrol. 2025.12; ( PubMed , DOI )

  2. Margaret F Meagher, Giacomo Musso, Viraj Master, Hajime Tanaka, Umberto Capitanio, Allesandro Larcher, Mai Dabbas, Dattatraya Patil, Wei Chen, Dhruv Puri, Benjamin H Baker, Shamsunnahar Imtiaz, Cesare Saitta, Shohei Fukuda, Masaki Kobayashi, Andrea Salonia, Alberto Briganti, Yasuhisa Fujii, Francesco Montorsi, Ithaar H Derweesh: Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary system. Urol Oncol. 2025.12; 43 (12): 706.e1-706.e10. ( PubMed , DOI )

  3. Hiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, Noboru Numao, Atsushi Yoshinaga, Naoko Kawamura, Kenji Tanabe, Keita Izumi, Takanobu Yamamoto, Sho Uehara, Yuya Maezawa, Takahiko Soma, Ryoji Takazawa, Saori Araki, Soichiro Yoshida, Yasuhisa Fujii: Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA Study. Clin Genitourin Cancer. 2025.12; 23 (6): 102426. ( PubMed , DOI )

  4. Wei Chen, Hajime Tanaka, Soichiro Yoshida, Shunya Matsumoto, Masaki Kobayashi, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Yasuhisa Fujii: Comparisons of Pembrolizumab Plus Lenvatinib, Nivolumab Plus Cabozantinib, and Cabozantinib Monotherapy in Advanced Non-Clear Cell Renal Cell Carcinoma Based on Individual Patient Data Reconstruction. Clin Genitourin Cancer. 2025.12; 23 (6): 102458. ( PubMed , DOI )

  5. Wei Chen, Soichiro Yoshida, Akihiro Hirakawa, Hiroyuki Sato, Shugo Yajima, Masaki Kobayashi, Motohiro Fujiwara, Hiroshi Fukushima, Yuki Arita, Yuma Waseda, Hajime Tanaka, Hitoshi Masuda, Yasuhisa Fujii: Clinical efficacy of apalutamide in Asian patients with metastatic castration-sensitive prostate cancer: Bayesian reanalysis of the TITAN trial. Jpn J Clin Oncol. 2025.12; ( PubMed , DOI )

  6. Wei Chen, Soichiro Yoshida, Koichiro Kimura, Yuki Arita, Yasuhisa Fujii: Time-dependent Treatment Effects of Prostate-specific Membrane Antigen Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer in the ENZA-p (ANZUP1901) Trial. Eur Urol Focus. 2025.12; ( PubMed , DOI )

  7. Tetsuya Wako, Go Kimura, Yasuhisa Fujii, Takahiro Osawa, Yosuke Uchitomi, Kazunori Honda, Miki Kondo, Ariko Otani, Yoshihide Mitsuda, Nobuo Shinohara: Perceptions and Expectations of Pharmacist Interventions in Adverse Event Management During Drug Therapy for Metastatic Renal Cell Carcinoma: A Cross-Sectional Survey in Japan. Cancers (Basel). 2025.12; 17 (24): ( PubMed , DOI )

  8. Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, Neal D Shore, Ashley E Ross, Andreas Røder, Andrea Juliana Gomes, Stephane Supiot, Philippe Barthélémy, Koji Hatano, Carmen Belen Congregado Ruiz, Soichiro Yoshida, Bernardo Herrera-Imbroda, Matthieu Gratton, Jürgen E Gschwend, Thomas A Hope, Heikki Joensuu, Iris Kuss, Marie-Aude Le Berre, Miryana Dimova-Dobreva, Karim Fizazi: Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP). Future Oncol. 2025.11; 21 (27): 3491-3498. ( PubMed , DOI )

  9. Giacomo Musso, Natalie Birouty, Andrea Salonia, Giuseppe Garofano, Mai Dabbas, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Cesare Saitta, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Umberto Capitanio, Alessandro Larcher, Giuseppe Rosiello, Yasuhisa Fujii, Viraj A Master, Ithaar H Derweesh: Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling. Urology. 2025.11; 205 99-107. ( PubMed , DOI )

  10. Soichiro Yoshida, Yosuke Yasuda, Yasuhisa Fujii: Editorial Comment to "Effects of Modifying Hinotori Surgical Robot System on the Surgical Step of the Dissection of the Renal Hilum and the Kidney Isolation". Int J Urol. 2025.11; 32 (11): 1707-1708. ( PubMed , DOI )

  11. Yosuke Yasuda, Zijie Wang, Soichiro Yoshida, Wei Chen, Hajime Tanaka, Yasuhisa Fujii: Indirect Comparison of PROpel and TALAPRO-2 Trials Using the Shiny Method: A Comparative Analysis in Metastatic Castration-Resistant Prostate Cancer. Int J Urol. 2025.11; 32 (11): 1709-1711. ( PubMed , DOI )

  12. Tomoki Kimura, Motohiro Fujiwara, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study). Int J Urol. 2025.10; 32 (10): 1369-1378. ( PubMed , DOI )

  13. Yosuke Yasuda, Noboru Numao, Shunya Matsumoto, Takashi Tamiya, Yuki Nakamura, Hajime Tanaka, Soichiro Yoshida, Shuichiro Kobayashi, Ryoji Takazawa, Yoh Matsuoka, Junji Yonese, Yasuhisa Fujii: Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study. Int J Urol. 2025.10; 32 (10): 1413-1418. ( PubMed , DOI )

  14. Shunya Matsumoto, Yuma Waseda, Masaki Kobayashi, Yuki Nakamura, Yudai Ishikawa, Hiroshi Fukushima, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Incidence of Low-risk Upper Tract Urothelial Carcinoma in Candidates for Kidney-sparing Surgery. Anticancer Res. 2025.10; 45 (10): 4333-4341. ( PubMed , DOI )

  15. Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, Mattia Longoni, Alfonso Santangelo, José Daniel Subiela, Roberto Contieri, Luca Afferi, Stefania Zamboni, Nazareno Suardi, Gennaro Musi, Stefano Luzzago, David D'Andrea, Ekaterina Laukhtina, Francesco Soria, Paolo Gontero, Francesco Del Giudice, Muhammad Shamim Khan, Ramesh Thurairaja, Morgan Roupret, Elisabeth Grobet-Jeandin, Arthur Baudewyns, Hajime Tanaka, Shunya Matsumoto, Yasuhisa Fujii, Flavia Proietti, Giuseppe Simone, Gerald Bastian Schulz, Nicolaos Pyrgidis, Guillaume Ploussard, Alessandro Antonelli, Riccardo Bertolo, Mathieu Roumiguie, Anne-Sophie Bajeot, Maria Carme Mir, Paolo Umari, Jeremy Teoh, Chris Wong, Laura S Mertens, Renate Pichler, Keiichiro Mori, Aleksander Ślusarczyk, Cédric Poyet, Simone Albisinni, Atiqullah Aziz, Alessandro Volpe, Shahrokh Shariat, Benjamin Pradere, Pierre Karakiewicz, Stefano Resca, Edoardo Beatrici, Ruben De Groote, Alexandre Mottrie, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Marco Moschini, : Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study. World J Urol. 2025.10; 43 (1): 636. ( PubMed , DOI )

  16. Cesare Saitta, Giacomo Musso, Giuseppe Garofano, Hajime Tanaka, Dattatraya Patil, Margaret F Meagher, Srinivas Vourganti, Edward Cherullo, Michael Liss, Marco Paciotti, Giovanni Lughezzani, Nicolò M Buffi, Viraj Master, Yasuhisa Fujii, Rana R McKay, Ithaar H Derweesh: Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma. Cancers (Basel). 2025.10; 17 (21): ( PubMed , DOI )

  17. Naoki Fujita, Yuto Matsushita, Takahiro Kojima, Yukari Bando, Takahiro Osawa, Tomokazu Sazuka, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Yoshihide Kawasaki, Takuma Kato, Makito Miyake, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Hiroshi Kitamura, Hideaki Miyake, Shingo Hakakeyama, : Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study. Int J Urol. 2025.10; 32 (10): 1506-1517. ( PubMed , DOI )

  18. Giacomo Musso, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Omer Baker, Aaron Ahdoot, Dhruv Puri, Mai Dabbas, Natalie Birouty, Cesare Saitta, Melis Guer, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Andrea Salonia, Umberto Capitanio, Alessandro Larcher, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinoma. Urol Oncol. 2025.08; 43 (8): 470.e1-470.e9. ( PubMed , DOI )

  19. Hara K, Murakami M, Shiba K, Tsujimoto K, Komiya C, Ikeda K, Yamamoto K, Taguchi T, Akashi T, Yoshida S, Ohashi K, Fujii Y, Yamada T.: Unexpected Remission of Bilateral Hyperaldosteronism After Unilateral Cortisol-Producing Adenoma Resection: A Report of Two Cases. Case Rep Endocrinol.. 2025.06; 9941688 ( PubMed )

  20. Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii: Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study). Int J Clin Oncol. 2025.06; 30 (6): 1237-1246. ( PubMed , DOI )

  21. Cesare Saitta, Riccardo Autorino, Umberto Capitanio, Giovanni Lughezzani, Margaret F Meagher, Kendrick Yim, Mimi V Nguyen, Matilde Mantovani, Melis Guer, Daniele Amparore, Federico Piramide, Kevin Hakimi, Dattatraya Patil, Hajime Tanaka, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Savio D Pandolfo, Julian Cortes, Dhruv Puri, Kit Yuen, Massimo Lazzeri, Vittorio Fasulo, Alessandro Larcher, Marco Paciotti, Giuseppe Garofano, Francesco Porpiglia, Francesco Montorsi, Yasuhisa Fujii, Viraj Master, Nicolò M Buffi, Ithaar H Derweesh: Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma. Clin Genitourin Cancer. 2025.06; 23 (3): 102343. ( PubMed , DOI )

  22. Cesare Saitta, Giuseppe Garofano, Giacomo Musso, Hajime Tanaka, Dattatraya Patil, Vi Nguyen, Kit L Yuen, Benjamin Baker, Mai Dabbas, Margaret F Meagher, Dhruv Puri, Natalie Birouty, Omer Baker, Masaki Kobayashi, Shohei Fukuda, Marco Paciotti, Giovanni Lughezzani, Alessandro Larcher, Umberto Capitanio, Riccardo Melloni, Mario Catanzaro, Sebastiano Nazzani, Nicola Nicolai, Yasuhisa Fujii, Viraj Master, Nicolòmaria Buffi, Ithaar H Derweesh: UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion. World J Urol. 2025.06; 43 (1): 355. ( PubMed , DOI )

  23. Shugo Yajima, Shinro Hata, Naoya Masumori, Yoh Matsuoka, Atsuro Sawada, Jun Miki, Mitsuhiro Tambo, Yasuyuki Kobayashi, Ayumu Matsuda, Keita Nakane, Takashi Kobayashi, Hajime Tanaka, Noriya Yamaguchi, Go Kaneko, Russell Miller, Takehiro Seto, Hiroaki Ito, Eiji Kikuchi: Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan. Int J Urol. 2025.06; 32 (6): 688-697. ( PubMed , DOI )

  24. Masayuki Takahashi, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Takahiro Kimura, Naotaka Nishiyama, Shimpei Yamashita, Hisanori Taniguchi, Keisuke Monji, Ryo Ishiyama, Yoshihide Kawasaki, Takuma Kato, Shuichi Tatarano, Kimihiko Masui, Eijiro Nakamura, Tomoyuki Kaneko, Makito Miyake, Goshi Kitano, Takanobu Motoshima, Yusuke Shiraishi, Satoru Kira, Takaya Murashima, Hiroaki Hara, Masafumi Matsumura, Hiroshi Kitamura, Hideaki Miyake, Junya Furukawa, : Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2025.06; 23 (3): 102322. ( PubMed , DOI )

  25. Chen W, Tanaka H, Kobayashi M, Fukuda S, Nakayama A, Meagher F M, Yoshida S, Derweesh I H, Master V A, Hirakawa A, Fujii Y, Saito K.: Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC study. Int J Urol. 2025.04; 32 (4): 414-422. ( PubMed , DOI )

  26. Waseda Y, Chen W, Yokoyama M, Fukuda S, Tanaka H, Yoshida S, Ai M, Hirakawa A, Fushimi K, Fujii Y.: Impact of surgical volume on outcomes of laparoscopic adrenalectomy for benign adrenal tumors: A Japanese nationwide database analysis. Int J Urol. 2025.04; 32 (4): 409-413. ( PubMed , DOI )

  27. Pioneering AI-guided fluorescence-like navigation in urological surgery: real-time ureter segmentation during robot-assisted radical cystectomy using convolutional neural network. 2025.04; 19 (1): 188. ( PubMed , DOI )

  28. Rikuto Yasujima, Hajime Tanaka, Junichi Tsuchiya, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii: F-fluorodeoxyglucose positron emission tomography/computed tomography on treatment response to pembrolizumab in patients with metastatic urothelial carcinoma. Int J Urol. 2025.04; 32 (4): 453-455. ( PubMed , DOI )

  29. Yuki Nakamura, Hajime Tanaka, Noboru Numao, Masaharu Inoue, Atsushi Yoshinaga, Naoko Kawamura, Kenji Tanabe, Keita Izumi, Takanobu Yamamoto, Sho Uehara, Yuya Maezawa, Takahiko Soma, Masahiro Toide, Ryoji Takazawa, Saori Araki, Soichiro Yoshida, Yasuhisa Fujii: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study). Clin Genitourin Cancer. 2025.04; 23 (2): 102301. ( PubMed , DOI )

  30. Patrizia Giannatempo, Jean-Pascal Machiels, Naoto Sassa, Jose Angel Arranz, Yasuhisa Fujii, Wen-Pin Su, Bhumsuk Keam, Stéphane Culine, Ying-Chun Shen, José Muñoz Langa, David Sarid, Maureen Aarts, Fabio Calabrò, Eli Rosenbaum, Blanca Homet Moreno, Abhishek Bavle, Jin Z Xu, Sun Young Rha: Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials. Clin Genitourin Cancer. 2025.04; 23 (2): 102273. ( PubMed , DOI )

  31. Wei Chen, Soichiro Yoshida, Yasuhisa Fujii: Is Docetaxel Essential for Darolutamide-Based Metastatic Hormone-Sensitive Prostate Cancer Therapy? Int J Urol. 2025.04; ( PubMed , DOI )

  32. Hiroshi Kikuchi, Takahiro Osawa, Yuto Matsushita, Takahiro Kojima, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kosuke Ueda, Hajime Tanaka, Toshifumi Kurahashi, Yukari Bando, Takahiro Kimura, Naotaka Nishiyama, Takuma Kato, Hiroaki Hara, Yoichi Ito, Hiroshi Kitamura, Hideaki Miyake, Nobuo Shinohara: Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study. Jpn J Clin Oncol. 2025.04; 55 (5): 531-538. ( PubMed , DOI )

  33. Yamaya N, Kimura K, Ichikawa R, Kawanishi M, Kawasaki Y, Higuchi S, Fukui K, Tsuchiya J, Kobayashi M, Yoshida S, Fujii Y, Tateishi U: Prospective evaluation of PI-RADSv2.1 using multiparametric and biparametric MRI for detecting clinically significant prostate cancer based on MRI/US fusion-guided biopsy. Japanese journal of radiology. 2025.03; 43 (3): 472-482. ( PubMed , DOI )

  34. Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Yasuhisa Fujii, Peter L Choyke, Hisataka Kobayashi: Antitumor host immunity enhanced by near-infrared photoimmunotherapy. Cancer Sci. 2025.03; 116 (3): 572-580.

  35. Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Ryo Takeshita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii: The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol. 2025.03; 32 (3): 264-269.

  36. Yamamoto T, Yoshida S, Maezawa Y, Tamiya T, Toide M, Fukushima H, Uehara S, Araki S, Ito M, Kobayashi S, Yoshinaga A, Kawamura N, Takazawa R, Sakai Y, Ootsuka Y, Tsukamoto T, Nagahama K, Tanaka H, Kitabayashi R, Hanazawa R, Ishiguro M, Sato H, Koike R, Fujii Y: Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocol BMJ Open. 2025.03; 15 (3): e094230. ( PubMed , DOI )

  37. Kohei Isemoto, Yuma Waseda, Motohiro Fujiwara, Koichiro Kimura, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Yuki Arita, Thomas C Kwee, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer. Diagnostics (Basel). 2025.03; 15 (7): ( PubMed , DOI )

  38. Kanami Mori, Kazuyuki Numakura, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazutoshi Yamana, Shuya Kandori, Takahiro Kimura, Naotaka Nishiyama, Yukari Bando, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Hiroshi Kitamura, Hideaki Miyake, Tomonori Habuchi: Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma. Cancer Sci. 2025.02; 116 (2): 444-452. ( PubMed , DOI )

  39. Mori M, Mori Y, Nakao Y, Mandai S, Fujiki T, Kikuchi H, Ando F, Susa K, Mori T, Waseda Y, Yoshida S, Fujii Y, Sohara E, Uchida S: Development of Adult Renal Tubular Organoids from Different Human Individuals in a Single Medium. JMA journal. 2025.01; 8 (1): 191-197. ( PubMed , DOI )

  40. Toshinari Horie, Motohiro Fujiwara, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Radiomics analysis using non-contrast computed tomography for predicting high-dependency unit admission in patients with acute pyelonephritis. Int J Urol. 2025.01; 32 (1): 121-123. ( PubMed , DOI )

  41. Wei Chen, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Akinori Nakayama, Margaret F Meagher, Rachel Greenwald, Benjamin Schmeusser, Edouard Nicase, Yuma Waseda, Soichiro Yoshida, Ithaar H Derweesh, Viraj A Master, Yasuhisa Fujii, Kazutaka Saito: Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry. World J Urol. 2025.01; 43 (1): 63. ( PubMed , DOI )

  42. Yuki Arita, Thomas C Kwee, Oguz Akin, Keisuke Shigeta, Ramesh Paudyal, Christian Roest, Ryo Ueda, Alfonso Lema-Dopico, Sunny Nalavenkata, Lisa Ruby, Noam Nissan, Hiromi Edo, Soichiro Yoshida, Amita Shukla-Dave, Lawrence H Schwartz: Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer. Insights Imaging. 2025.01; 16 (1): 7. ( PubMed , DOI )

  1. Kotaro Shimada, Motohiro Fujiwara, Daisuke Hirahara, Eichi Takaya, Soichiro Yoshida, Yasuhisa Fujii: Monitoring prostate cancer after low-dose-rate hemigland brachytherapy with delta-radiomics of diffusion-weighted magnetic resonance imaging. Int J Urol. 2024.12; 31 (12): 1443-1445. ( PubMed , DOI )

  2. Koichiro Kimura, Tatsuya Yamamoto, Junichi Tsuchiya, Soichiro Yoshida, Shuichi Yanai, Iichiro Onishi, Yasuhisa Fujii, Ukihide Tateishi: A diagnostic approach of various urethral diseases using multimodal imaging findings: comprehensive overview. Abdom Radiol (NY). 2024.12; 49 (12): 4416-4436. ( PubMed , DOI )

  3. Cesare Saitta, Giuseppe Garofano, Jonathan A Afari, Hajime Tanaka, Dattatraya Patil, Kit L Yuen, Luke Wang, Julian Cortes, Margaret F Meagher, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Masaki Kobayashi, Shohei Fukuda, Marco Paciotti, Massimo Lazzeri, Giovanni Lughezzani, Nicolò M Buffi, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2024.12; 22 (6): 102232. ( PubMed , DOI )

  4. Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii: Efficacy of docetaxel addition to next-generation androgen receptor-axis-targeted therapies and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: A tumor volume-specific analysis. Int J Urol. 2024.12; ( PubMed , DOI )

  5. Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Ryo Takeshita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii: The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol. 2024.12; ( PubMed , DOI )

  6. Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Yasuhisa Fujii, Peter L Choyke, Hisataka Kobayashi: Antitumor host immunity enhanced by near-infrared photoimmunotherapy. Cancer Sci. 2024.12; ( PubMed , DOI )

  7. Yuya Maezawa, Masaki Kobayashi, Masanori Murakami, Ayumi Yamamura, Shotaro Naito, Hajime Tanaka, Soichiro Yoshida, Tetsuya Yamada, Yasuhisa Fujii: Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient. IJU Case Rep. 2024.11; 7 (6): 431-433. ( PubMed , DOI )

  8. Yuki Nakamura, Yudai Ishikawa, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies. Int J Urol. 2024.11; 31 (11): 1263-1268. ( PubMed , DOI )

  9. Soichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii: Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases. Int J Urol. 2024.11; 31 (11): 1234-1240. ( PubMed , DOI )

  10. Yanagi, T; Kikuchi, H; Takeuchi, K; Susa, K; Mori, T; Chiga, M; Yamamoto, K; Furukawa, A; Kanazawa, T; Kato, Y; Takahashi, N; Suzuki, T; Mori, Y; Carter, BC; Mori, M; Nakano, Y; Fujiki, T; Hara, Y; Suzuki, S; Ando, F; Mandai, S; Honda, S; Torii, S; Shimizu, S; Tanaka, H; Fujii, Y; Rai, T; Uchida, S; Sohara, E: ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease KIDNEY INTERNATIONAL. 2024.11; 106 (5): 887-906. ( PubMed , DOI )

  11. Franklin Liu, Luke Wang, Margaret F Meagher, Jonathan Afari, Cesare Saitta, Sohail Dhanji, Saeed Ghassemzadeh, Aastha Shah, Dhruv Puri, Mimi V Nguyen, Kevin Hakimi, Benjamin Schmeusser, Rachel Greenwald, Alexandra Medline, Fatima Kamal, Adil Ali, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Bo Fan, Yusuke Aida, Yuya Maezawa, Shintaro Asai, Hajime Tanaka, Dattatraya Patil, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database. Urol Oncol. 2024.10; 42 (10): 333.e21-333.e31. ( PubMed , DOI )

  12. Julian A Cortes, Cesare Saitta, Kit L Yuen, Dattatraya Patil, Hajime Tanaka, Dhruv Puri, Jonathan A Afari, Mirha Mahmood, Joshua Matian, Mariam Mansour, Aaron Ahdoot, Luke Wang, Margaret F Meagher, Melis Guer, Mai Dabbas, Mimi V Nguyen, Clara Cerrato, Masaki Kobayashi, Shohei Fukuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry. Clin Genitourin Cancer. 2024.10; 22 (5): 102126. ( PubMed , DOI )

  13. Tanaka H, Yoshida S, Aoyama S, Ikeda S, Kunieda J, Ohashi K, Fukuda S, Waseda Y, Tanaka H, Fujii Y: A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab. IJU case reports. 2024.09; 7 (5): 395-398. ( PubMed , DOI )

  14. Kenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study. Int J Clin Oncol. 2024.09; 29 (9): 1302-1310. ( PubMed , DOI )

  15. Hajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, Kousuke Tanimoto, Akira Takemoto, Takayasu Mori, Hisashi Hasumi, Mayumi Kinoshita, Takumi Kanazawa, Asuka Furukawa, Koichiro Kimura, Hiroyuki Sato, Akihiro Hirakawa, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Steven C Campbell, Yasuhisa Fujii: Prognostic impact and genomic backgrounds of renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma. Mod Pathol. 2024.08; 100590. ( PubMed , DOI )

  16. Fujiwara M, Shimada W, Yokoyama M, Koyanagi A, Shintaku H, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y: Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU case reports. 2024.07; 7 (4): 293-296. ( PubMed , DOI )

  17. Masahiro Toide, Hajime Tanaka, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Koichiro Kimura, Yuma Waseda, Soichiro Yoshida, Ukihide Tateishi, Yasuhisa Fujii: Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study. Int J Urol. 2024.07; 31 (7): 778-784. ( PubMed , DOI )

  18. Kobayashi M, Matsuoka Y, Uehara S, Tanaka H, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y: Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2024.07; 31 (7): 739-746. ( PubMed , DOI )

  19. Cesare Saitta, Jonathan A Afari, Dattatraya Patil, Hajime Tanaka, Kit L Yuen, Luke Wang, Julian Cortes, Franklin Liu, Mirha Mahmood, Joshua Matian, Mariam Mansour, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Masaki Kobayashi, Shohei Fukuda, Margaret F Meagher, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry. Clin Genitourin Cancer. 2024.06; 22 (3): 102098. ( PubMed , DOI )

  20. Shintaro Asai, Masaki Kobayashi, Shohei Fukuda, Koichiro Kimura, Soichiro Yoshida, Yasuhisa Fujii: Significance of atypical nodules upgraded to category 3 in Prostate Imaging Reporting and Data System version 2.1 for prostate cancer diagnosis. Int J Urol. 2024.06; 31 (6): 693-695. ( PubMed , DOI )

  21. Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake, : Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. Int J Urol. 2024.05; 31 (5): 526-533. ( PubMed , DOI )

  22. Cesare Saitta, Jonathan A Afari, Arman Walia, Dattatraya Patil, Hajime Tanaka, Kevin Hakimi, Luke Wang, Margaret F Meagher, Franklin Liu, Mimi V Nguyen, Dhruv Puri, Clara Cerrato, Ava Saidian, Masaki Kobayashi, Shohei Fukuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry. Urol Oncol. 2024.04; 42 (4): 119.e1-119.e16. ( PubMed , DOI )

  23. Motohiro Fujiwara, Hajime Tanaka, Masaki Kobayashi, Yuki Nakamura, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Yasuhisa Fujii: Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clin Genitourin Cancer. 2024.04; 22 (2): 193-200.e1.

  24. Tateishi U, Kimura K, Tsuchiya J, Kano D, Watabe T, Nonomura N, Saito K, Yokoyama K, Yamagiwa K, Adachi T, Kojima Y, Yoshida S, Fujii Y: Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Japanese journal of clinical oncology. 2024.03; 54 (3): 282-291. ( PubMed , DOI )

  25. Ukihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, Daisuke Kano, Tadashi Watabe, Norio Nonomura, Katsuhiko Saito, Kota Yokoyama, Ken Yamagiwa, Takuya Adachi, Yuji Kojima, Soichiro Yoshida, Yasuhisa Fujii: Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Jpn J Clin Oncol. 2024.03; 54 (3): 282-291.

  26. Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii: Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Low Urin Tract Symptoms. 2024.01; 16 (1): e12507.

  27. Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii: Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. Front Oncol. 2024; 14 1527540.

  28. Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii: Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. Front Oncol. 2024; 14 1527540.

  29. Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. 2024; 14 1527540. ( PubMed , DOI )

  1. Matsuoka Y, Ueno Y, Uehara S, Tanaka H, Kobayashi M, Tanaka H, Yoshida S, Yokoyama M, Kumazawa I, Fujii Y: Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging. International journal of urology : official journal of the Japanese Urological Association. 2023.12; 30 (12): 1103-1111. ( PubMed , DOI )

  2. Yudai Ishikawa, Hajime Tanaka, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii: Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid. Int J Urol. 2023.11; 31 (3): 238-244. ( PubMed , DOI )

  3. Sazuka T, Matsushita Y, Sato H, Osawa T, Hinata N, Hatakeyama S, Numakura K, Ueda K, Kimura T, Takahashi M, Tanaka H, Kawasaki Y, Kurahashi T, Kato T, Fujita K, Miyake M, Kojima T, Kitamura H, Miyake H, Ichikawa T: Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study. Scientific reports. 2023.11; 13 (1): 20629. ( PubMed , DOI )

  4. Ohba Kojiro, Monji Keisuke, Osawa Takahiro, Yamana Kazutoshi, Yasuda Yosuke, Tanaka Hajime, Nakagawa Yuki, Fukuyama Tamaki, Matsubara Nobuaki, Uemura Hirotsugu, Sakai Hideki, Eto Masatoshi: Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 977-984. ( 医中誌 )

  5. Ohba K, Monji K, Osawa T, Yamana K, Yasuda Y, Tanaka H, Nakagawa Y, Fukuyama T, Matsubara N, Uemura H, Sakai H, Eto M: Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 977-984. ( PubMed , DOI )

  6. Kaneko Hiroki, Fujiwara Motohiro, Tanaka Hajime, Kimura Koichiro, Yoshida Soichiro, Fujii Yasuhisa: Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 1056-1058. ( 医中誌 )

  7. Chen Wei, Yokoyama Minato, Waseda Yuma, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa: Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 1014-1019. ( 医中誌 )

  8. Fujiwara M, Tanaka H, Kobayashi M, Nakamura Y, Fan B, Ishikawa Y, Fukuda S, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Fujii Y: Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clinical genitourinary cancer. 2023.11; ( PubMed , DOI )

  9. Chen W, Yokoyama M, Waseda Y, Kobayashi M, Fan B, Fukuda S, Tanaka H, Yoshida S, Ai M, Fushimi K, Fujii Y: Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 1014-1019. ( PubMed , DOI )

  10. Kataoka M, Yokoyama M, Waseda Y, Ito M, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Masuda H, Fujii Y: Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Lower urinary tract symptoms. 2023.11; ( PubMed , DOI )

  11. Fan B, Yokoyama M, Kobayashi M, Nakamura Y, Fujiwara M, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y: Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years. International journal of urology : official journal of the Japanese Urological Association. 2023.10; 31 (2): 119-124. ( PubMed , DOI )

  12. Yamaguchi Yoshitomo, Tanaka Hajime, Kimura Koichiro, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yoshida Soichiro, Yokoyama Minato, Hirakawa Akihiro, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa: Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma(タイトル和訳中) International Journal of Urology. 2023.10; 30 (10): 913-921. ( 医中誌 )

  13. Soma T, Yoshida S, Wakejima R, Taguchi T, Fukuda S, Tanaka H, Yokoyama M, Ohashi K, Okubo K, Fujii Y: A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy. IJU case reports. 2023.07; 6 (4): 216-218. ( PubMed , DOI )

  14. Yoshida Soichiro, Takahara Taro, Tanaka Hajime, Yokoyama Minato, Yoshimura Ryoichi, Fujii Yasuhisa: The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer International Journal of Urology. 2023.07; 30 (7): 616-617. ( 医中誌 )

  15. Soma Takahiko, Yoshida Soichiro, Wakejima Ryo, Taguchi Towako, Fukuda Shohei, Tanaka Hajime, Yokoyama Minato, Ohashi Kenichi, Okubo Kenichi, Fujii Yasuhisa: A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy IJU Case Reports. 2023.07; 6 (4): 216-218. ( 医中誌 )

  16. Yamaguchi Y, Tanaka H, Kimura K, Fukuda S, Fukushima H, Waseda Y, Yoshida S, Yokoyama M, Hirakawa A, Tateishi U, Campbell SC, Fujii Y: Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2023.06; ( PubMed , DOI )

  17. Soma Takahiko, Fukuda Shohei, Matsuyama Yusuke, Ikeda Riko, Inoue Masaharu, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujiwara Takeo, Kageyama Yukio, Fujii Yasuhisa: ロボット支援前立腺全摘除術後の鼠径ヘルニア予防のための腹膜閉鎖および鞘状突起離断法(Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy) International Journal of Urology. 2023.06; 30 (6): 532-538. ( 医中誌 )

  18. Kimura K, Yoshida S, Tsuchiya J, Kitazume Y, Waseda Y, Tanaka H, Yokoyama M, Toda K, Yoshimura R, Masaya I, Koga F, Tateishi U, Fujii Y: Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. European radiology. 2023.04; ( PubMed , DOI )

  19. Nakamura Yuki, Fukushima Hiroshi, Yoshitomi Kasumi, Soma Takahiko, Kobayashi Masaki, Fan Bo, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa: 筋層非浸潤性膀胱癌の増悪予測における背側膀胱頸部浸潤の重要性(Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer) International Journal of Urology. 2023.04; 30 (4): 381-388. ( 医中誌 )

  20. Uchida Y, Yokoyama M*, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujiwara T, Fujii Y: Preservation of erectile and ejaculatory functions after tetramodal bladder-sparing therapy incorporating consolidative partial cystectomy against muscle invasive bladder cancer. Urology Research and Practice. 2023.04; ( DOI )

  21. Chen Wei, Yokoyama Minato, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Nonomura Norio, Fujii Yasuhisa: 根治的膀胱摘除術の動向およびロボット支援根治的膀胱摘除術に注目した外科的アプローチ間の手術成績の比較　日本の全国データベース研究(Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study) International Journal of Urology. 2023.03; 30 (3): 258-263. ( 医中誌 )

  22. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y: Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study. Japanese journal of clinical oncology. 2023.03; 53 (3): 263-269. ( PubMed , DOI )

  23. Fujiwara Motohiro, Yokoyama Minato, Toide Masahiro, Fujiwara Ryo, Tanaka Hajime, Oguchi Tomohiko, Komai Yoshinobu, Yoshida Soichiro, Matsuoka Yoh, Numao Noboru, Yamamoto Shinya, Fukui Iwao, Yonese Junji, Fujii Yasuhisa: 筋層浸潤性膀胱癌患者に対する最大限の経尿道的切除術、導入化学放射線療法、地固め部分膀胱切除術からなる選択的4者併用膀胱温存療法後の腎機能転帰と根治的膀胱全摘術後の腎機能転帰との比較　2施設後ろ向き研究(Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study) Japanese Journal of Clinical Oncology. 2023.03; 53 (3): 263-269. ( 医中誌 )

  24. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive sitedirected therapy International Journal of Urology. 2023.02; 30 (2): 204-210. ( 医中誌 )

  25. Hajime Tanaka, Shohei Fukuda, Koichiro Kimura, Yuki Fukawa, Kouhei Yamamoto, Hiroshi Fukushima, Shingo Moriyama, Yosuke Yasuda, Sho Uehara, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii: Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma. Eur Urol Open Sci. 2023.02; 48 36-43. ( PubMed , DOI )

  26. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH: Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma. BJU international. 2023.02; 131 (2): 219-226. ( PubMed , DOI )

  1. Julia H Yuan, Hajime Tanaka, Dattatraya Patil, Kevin Hakimi, Shady Soliman, Margaret F Meagher, Ava Saidian, Arman Walia, Sohail Dhanji, Franklin Liu, Jonathan Afari, Mimi Nguyen, Luke Wang, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 2022.12; 21 (4): e219-e227. ( PubMed , DOI )

  2. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y: Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

  3. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii: Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; ( PubMed , DOI )

  4. Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y: Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed , DOI )

  5. Shimada Wataru, Kimura Koichiro, Tanaka Hajime, Fukuda Shohei, Yoshida Soichiro, Fujii Yasuhisa: Significance of tumor shape irregularity: Radiomics analysis based on dynamic computed tomography for predicting pT3a upstaging in cT1b-2N0M0 renal cell carcinoma International Journal of Urology. 2022.11; 29 (11): 1387-1389. ( 医中誌 )

  6. Yamaguchi Yoshitomo, Yokoyama Minato, Takemoto Akira, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa: コハク酸脱水素酵素欠損性腎細胞癌を合併したコハク酸脱水素酵素欠損性の悪性パラガングリオーマ(Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma) IJU Case Reports. 2022.11; 5 (6): 480-483. ( 医中誌 )

  7. Arita Y, Yoshida S, Shigeta K, Kwee TC, Edo H, Okawara N, Hashimoto M, Ishii R, Ueda R, Mikami S, Fujiwara M, Waseda Y, Kikuchi E, Fujii YJinzaki M: Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology Eur Urol Oncol . 2022.08; ( DOI )

  8. Tanaka H, Fujii Y: Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma Int J Urol. 2022.08; 29 (8): 822-823.

  9. Shumpei Yamamoto, Hiroshi Fukushima, Shohei Fukuda, Sho Uehara, Yosuke Yasuda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii: Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia Pac J Clin Oncol. 2022.08; 18 (4): 410-418. ( PubMed , DOI )

  10. Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y: Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia Pac J Clin Oncol . 2022.08; 18 (4): 410-418.

  11. Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y: Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clin Genitourin Cancer. 2022.08; 20 (4): 276-282.

  12. Tanaka H, Fujii Y: Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2022.08; 29 (8): 822-823. ( PubMed , DOI )

  13. Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y: Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clinical genitourinary cancer. 2022.08; 20 (4): e276-e282. ( PubMed , DOI )

  14. Tanaka Hajime, Fujii Yasuhisa: 「進行性腎細胞癌の一次治療としての複合癌免疫療法の包括的評価」に対するエディトリアルコメント(Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma) International Journal of Urology. 2022.08; 29 (8): 822-823. ( 医中誌 )

  15. Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y: Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation Abdom Radiol (NY) . 2022.06; 47 (6): 2178-2186.

  16. Shunya Matsumoto, Yuki Arita, Soichiro Yoshida, Hiroshi Fukushima, Koichiro Kimura, Ichiro Yamada, Hajime Tanaka, Fumiko Yagi, Minato Yokoyama, Yoh Matsuoka, Mototsugu Oya, Ukihide Tateishi, Masahiro Jinzaki, Yasuhisa Fujii: Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation. Abdom Radiol (NY). 2022.06; 47 (6): 2178-2186. ( PubMed , DOI )

  17. Tanaka H, Fujii Y: Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. Int J Urol. 2022.06; 29 (6): 501-502.

  18. Tanaka H, Fujii Y: Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. International journal of urology : official journal of the Japanese Urological Association. 2022.06; 29 (6): 501-502. ( PubMed , DOI )

  19. Tanaka Hajime, Fujii Yasuhisa: 「転移性腎細胞癌に対する外科的局所治療　文献レビュー」に対するエディトリアルコメント(Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review) International Journal of Urology. 2022.06; 29 (6): 501-502. ( 医中誌 )

  20. Nityam Rathi, Diego A Palacios, Emily Abramczyk, Hajime Tanaka, Yunlin Ye, Jianbo Li, Yosuke Yasuda, Robert Abouassaly, Mohamed Eltemamy, Alvin Wee, Christopher Weight, Steven C Campbell: Predicting GFR after radical nephrectomy: the importance of split renal function. World J Urol. 2022.04; 40 (4): 1011-1018. ( PubMed , DOI )

  21. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y: Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy Urol Oncol . 2022.04; 40 (4): 161.

  22. Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hiromi Edo, Ryohei Kufukihara, Keisuke Shigeta, Misa Nagasaka, Ryo Takeshita, Haruka Okamura, Ryo Ueda, Ryota Ishii, Shigeo Okuda, Yasuhisa Fujii: Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination. Eur J Radiol. 2022.03; 148 110163. ( PubMed , DOI )

  23. Yusuke Uchida, Soichiro Yoshida, Yuki Arita, Hiroki Shimoda, Koichiro Kimura, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Masahiro Jinzaki, Yasuhisa Fujii: Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Diagnostics (Basel). 2022.03; 12 (4): ( PubMed , DOI )

  24. Yoshida S, Matsushima H, Fujii Y: Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity World J Urol . 2022.03; 40 (3): 871-873.

  25. Yoshida S, Fujii Y: Editorial Comment from Dr Yoshida and Dr Fujii to Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: A diagnostic meta-analysis Int J Urol . 2022.03; 29 (3): 196.

  26. Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y: Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel). 2022.03; 12 (4): 817.

  27. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH: Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma BJU Int. 2022.02; 131 (2): 219-226.

  28. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y: Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response 2022.01; 14 (3): 567.

  29. Soichiro Yoshida, Taro Takahara, Yuki Arita, Kazuma Toda, Koichiro Kimura, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii: Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers (Basel). 2022.01; 14 (3): 567. ( PubMed , DOI )

  30. Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y: Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer Eur Radiol . 2022.01; 32 (1): 671-679.

  31. Yuki Arita, Hirotaka Akita, Hirokazu Fujiwara, Masahiro Hashimoto, Keisuke Shigeta, Thomas C Kwee, Soichiro Yoshida, Takeo Kosaka, Shigeo Okuda, Mototsugu Oya, Masahiro Jinzaki: Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements. Eur J Radiol Open. 2022; 9 100403. ( PubMed , DOI )

  32. Cathrine Keiner, Margaret Meagher, Dattatraya Patil, Kazutaka Saito, Arman Walia, Franklin Liu, Raksha Dutt, Nathan Miller, Sohail Dhanji, Ava Saidian, Fang Wan, Yosuke Yasuda, Yasuhisa Fujii, Hajime Tanaka, Viraj Master, Ithaar Derweesh: Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Front Oncol. 2022; 12 995991. ( PubMed , DOI )

  33. Preedanan W, Suzuki K, Kondo T, Kobayashi M, Tanaka H, Ishioka J, Matsuoka Y, Fujii Y, Kumazawa I: Improvement of Urinary Stone Segmentation Using GAN-Based Urinary Stones Inpainting Augmentation. IEEE Access. 2022;

  34. Rossi SH, Tanaka H, Usher-Smith JA, Bernhard JC, Fujii Y, Stewart GD : Kidney Cancer Screening and Epidemiology. Société Internationale d’Urologie Journal. 2022;

  35. Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I: Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Frontiers in oncology. 2022; 12 995991. ( PubMed , DOI )

  36. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y: Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

  1. Yudai Ishikawa, Hiroshi Fukushima, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Yasuyuki Sakai, Yukihiro Otsuka, Ryoji Takazawa, Masataka Yano, Tetsuro Tsukamoto, Tetsuo Okuno, Akira Noro, Katsushi Nagahama, Shigeyoshi Kamata, Yasuhisa Fujii: Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study. Diagnostics (Basel). 2021.12; 11 (12): 2277. ( PubMed , DOI )

  2. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y: Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urologic oncology. 2021.12; ( PubMed , DOI )

  3. Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa: Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018(和訳中) International Journal of Urology. 2021.12; 28 (12): 1268-1272. ( 医中誌 )

  4. Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y: Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

  5. Shimada Wataru, Tanaka Hajime, Fukawa Yuki, Kimura Koichiro, Yamamoto Kouhei, Fukuda Shohei, Fukushima Hiroshi, Yasuda Yosuke, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa: 局所進行腎細胞癌における浸潤性腫瘍の正常腎実質との界面　臨床的意義と病理学的意味(Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications) International Journal of Urology. 2021.12; 28 (12): 1233-1239. ( 医中誌 )

  6. Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hirotaka Akita, Shigeo Okuda, Yuki Iwaita, Kiyoko Mukai, Shunya Matsumoto, Ryo Ueda, Ryota Ishii, Ryuichi Mizuno, Yasuhisa Fujii, Mototsugu Oya, Masahiro Jinzaki: Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma. Eur J Radiol. 2021.10; 143 109895. ( PubMed , DOI )

  7. Maruyama Riko, Fukushima Hiroshi, Fukuda Shohei, Yasuda Yosuke, Uehara Sho, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: 副腎腫瘍および腎腫瘍の清潔手術における予防的抗菌薬の不使用　連続患者1362例を対象としたリスクベース戦略の結果(Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients) International Journal of Urology. 2021.10; 28 (10): 1032-1038. ( 医中誌 )

  8. Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa: Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018 INTERNATIONAL JOURNAL OF UROLOGY. 2021.09; 28 (12): 1268-1272. ( PubMed , DOI )

  9. Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese: First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed , DOI )

  10. Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Sosan Azizi, Kees Hendricksen, Alberto Martini, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Alessandro Tafuri, Alessandro Antonelli, Maria Angela Cerruto, Morgan Rouprêt, Alexandra Masson-Lecomte, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat, Francesco Soria, Giancarlo Marra, Paolo Gontero, Roberto Contieri, Rodolfo Hurle, Anne Sophie Valiquette, M Carmen Mir, Stefania Zamboni, Claudio Simeone, Tobias Klatte, Jeremy Yuen-Chun Teoh, Soichiro Yoshida, Yasuhisa Fujii, Roberto Carando, Gerald B Schulz, Livio Mordasini, Agostino Mattei, Marco Moschini, : Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. Eur Urol Focus. 2021.08; ( PubMed , DOI )

  11. Shimada W, Tanaka H, Fukawa Y, Kimura K, Yamamoto K, Fukuda S, Fukushima H, Yasuda Y, Uehara S, Yoshida S, Yokoyama M, Matsuoka Y, Tateishi U, Campbell SC, Fujii Y: Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. International journal of urology : official journal of the Japanese Urological Association. 2021.08; 28 (12): 1233-1239. ( PubMed , DOI )

  12. Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y: Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed , DOI )

  13. Yoshida S, Fujii Y: Editorial Comment to Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy. International journal of urology : official journal of the Japanese Urological Association. 2021.07; 28 (7): 756. ( PubMed , DOI )

  14. Maruyama R, Fukushima H, Fukuda S, Yasuda Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y: Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. International journal of urology : official journal of the Japanese Urological Association. 2021.07; ( PubMed , DOI )

  15. Yoshida Soichiro, Matsuoka Yoh, Toda Kazuma, Uehara Sho, Tanaka Hajime, Yokoyama Minato, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa: Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy IJU Case Reports. 2021.07; 4 (4): 228-230. ( 医中誌 )

  16. Kimura Koichiro, Yoshida Soichiro, Tsuchiya Junichi, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Tateishi Ukihide, Fujii Yasuhisa: Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer EUROPEAN RADIOLOGY. 2021.06; ( PubMed , DOI )

  17. Yoshida S, Takahara T, Arita Y, Sakaino S, Katahira K, Fujii Y: Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond. International journal of urology : official journal of the Japanese Urological Association. 2021.05; 28 (5): 502-513. ( PubMed , DOI )

  18. Yamazaki A, Ito T, Sugimoto M, Yoshida S, Honda K, Kawashima Y, Fujikawa T, Fujii Y, Tsutsumi T: Patient-specific virtual and mixed reality for immersive, experiential anatomy education and for surgical planning in temporal bone surgery. Auris, nasus, larynx. 2021.05; 48 (6): 1081-1091. ( PubMed , DOI )

  19. Arita Y, Yoshida S, Waseda Y, Takahara T, Ishii C, Ueda R, Kwee TC, Miyahira K, Ishii R, Okuda S, Jinzaki M, Fujii Y: Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer. European journal of radiology. 2021.04; 137 109581. ( PubMed , DOI )

  20. Yoshida S, Fujii Y: Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer. IJU case reports. 2021.03; 4 (2): 73-74. ( PubMed , DOI )

  21. Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa: Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique(和訳中) International Journal of Urology. 2021.03; 28 (3): 302-307. ( 医中誌 )

  22. Yoshida Soichiro, Fujii Yasuhisa: Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer(和訳中) IJU Case Reports. 2021.03; 4 (2): 73-74. ( 医中誌 )

  23. Yamamoto S, Yoshida S, Ishii C, Takahara T, Arita Y, Fukushima H, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y: Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. Journal of magnetic resonance imaging : JMRI. 2021.03; 54 (2): 401-408. ( PubMed , DOI )

  24. Sweet DE, Ward RD, Wang Y, Tanaka H, Campbell SC, Remer EM: Infiltrative Renal Malignancies: Imaging Features, Prognostic Implications, and Mimics. Radiographics : a review publication of the Radiological Society of North America, Inc. 2021.03; 41 (2): 487-508. ( PubMed , DOI )

  25. Yoshida Soichiro, Takahara Taro, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International Journal of Urology. 2021.02; 28 (2): 241-242. ( 医中誌 )

  26. Fukuda S, Saito K, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kageyama Y, Fujii Y: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. Journal for immunotherapy of cancer. 2021.02; 9 (2): ( PubMed , DOI )

  27. Tanaka H, Fujii Y: Editorial Comment. The Journal of urology. 2021.02; 205 (5): 101097JU000000000000154902-1320. ( PubMed , DOI )

  28. Fukushima Hiroshi, Yoshida Soichiro, Kijima Toshiki, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa: Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.01; 22 (2): ( PubMed , DOI )

  29. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa: Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems(和訳中) International Journal of Urology. 2021.01; 28 (1): 127-129. ( 医中誌 )

  30. Soma Takahiko, Yokoyama Minato, Uchida Yusuke, Kirimura Susumu, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa: 膀胱増大に起因する扁平上皮癌とリンパ節転移に対して根治的膀胱切除術と腸間膜リンパ節郭清を行い長期生存した症例　1症例報告(Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report) International Cancer Conference Journal. 2021.01; 10 (1): 20-23. ( 医中誌 )

  31. Yoshida S, Matsushima H, Fujii Y: Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity. World journal of urology. 2021.01; ( PubMed , DOI )

  32. Tanaka Hajime, Fujii Yasuhisa: Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 16. ( PubMed , DOI )

  33. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy INTERNATIONAL UROLOGY AND NEPHROLOGY. 2021.01; 53 (6): 1119-1125. ( PubMed , DOI )

  34. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa: Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 127-129. ( PubMed , DOI )

  35. Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y: Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed , DOI )

  36. Tanaka Hajime, Fujii Yasuhisa: 「膀胱癌に対するリンパ節郭清　現行の基準と最新のエビデンス」に対するエディトリアルコメント(Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence) International Journal of Urology. 2021.01; 28 (1): 16. ( 医中誌 )

  37. Saito Kazutaka, Matsuoka Yoh, Toda Kazuma, Yoshida Soichiro, Yokoyama Minato, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa: Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer BRACHYTHERAPY. 2021; 20 (4): 842-848. ( PubMed , DOI )

  38. Waseda Y, Yoshida S, Arita Y, Takahara T, Sakamoto T, Saito K, Fujii Y: Potential of Perfusion Magnetic Resonance Imaging to Predict Residual Renal Function after Radical Nephroureterectomy. Urologia internationalis. 2021; 105 (5-6): 507-513. ( PubMed , DOI )

  1. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation Low Urin Tract Symptoms. 2020.12;

  2. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y: Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique. International journal of urology : official journal of the Japanese Urological Association. 2020.12; ( PubMed , DOI )

  3. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. : Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique Int J Urol.. 2020.12;

  4. Tanaka Hajime: Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management(和訳中) International Journal of Urology. 2020.12; 27 (12): 1071. ( 医中誌 )

  5. Tanaka Hajime: Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management INTERNATIONAL JOURNAL OF UROLOGY. 2020.12; 27 (12): 1071. ( PubMed , DOI )

  6. Yoshida S, Takahara T, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y: Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International journal of urology : official journal of the Japanese Urological Association. 2020.11; ( PubMed , DOI )

  7. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer medicine. 2020.11; 9 (22): 8355-8363. ( PubMed , DOI )

  8. Palacios Diego Aguilar, Campbell Rebecca, Wang Yanbo, Tanaka Hajime, Ding Xiaobo, Ye Yun-Lin, Remer Erick M., Rizk Alain, Ward Ryan, Haywood Samuel, Campbell Steven C.: Infiltrative Renal Masses: Clinical Challenges UROLOGY. 2020.11; 145 3-8. ( PubMed , DOI )

  9. 田中 一, 木島 敏樹, 福田 翔平, 福島 啓司, 安田 庸輔, 森山 真吾, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久: 局所限局性浸潤性膀胱癌の実践治療　筋層浸潤膀胱癌に対する4者併用膀胱温存療法 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS13-1. ( 医中誌 )

  10. 福島 啓司, 木島 敏樹, 安田 庸輔, 森山 真吾, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 松岡 陽, 松原 伸晃, 湯浅 健, 増田 均, 米瀬 淳二, 影山 幸雄, 藤井 靖久: 進行・転移性膀胱癌治療のup-to-date　進行尿路上皮癌に対するペムブロリズマブ治療における化学放射線療法の意義 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS14-1. ( 医中誌 )

  11. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa: Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images(和訳中) International Journal of Urology. 2020.09; 27 (9): 760-766. ( 医中誌 )

  12. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y: Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report. Anti-cancer drugs. 2020.09; 31 (8): 866-871. ( PubMed , DOI )

  13. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer immunology, immunotherapy : CII. 2020.09; ( PubMed , DOI )

  14. Tanaka Hajime: Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision(和訳中) International Journal of Urology. 2020.09; 27 (9): 710. ( 医中誌 )

  15. Tanaka Hajime: Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision INTERNATIONAL JOURNAL OF UROLOGY. 2020.09; 27 (9): 710. ( PubMed , DOI )

  16. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab Cancer Immunol Immunother. 2020.09;

  17. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yoshimura Ryoichi, Fujii Yasuhisa: Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer(和訳中) International Journal of Urology. 2020.07; 27 (7): 634-635. ( 医中誌 )

  18. Kaneko Kasumi, Yoshida Soichiro, Yamamoto Kouhei, Arita Yuki, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging(和訳中) International Journal of Urology. 2020.07; 27 (7): 599-604. ( 医中誌 )

  19. Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clinical genitourinary cancer. 2020.07; ( PubMed , DOI )

  20. Yoshida Soichiro, Sugimoto Maki, Fukuda Shohei, Taniguchi Naoji, Saito Kazutaka, Fujii Yasuhisa: Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy (vol 27, pg 471, 2020) INTERNATIONAL JOURNAL OF UROLOGY. 2020.07; 27 (7): 636. ( DOI )

  21. Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review Clin Genitourin Cancer. 2020.07;

  22. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 599-604. ( PubMed , DOI )

  23. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y: Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 634-635. ( PubMed , DOI )

  24. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y: Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images. International journal of urology : official journal of the Japanese Urological Association. 2020.06; ( PubMed , DOI )

  25. Yoshida Soichiro, Taniguchi Naoji, Moriyama Shingo, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: MRI撮影-超音波検査融合画像による前立腺生検の患者説明におけるバーチャルリアリティの応用(Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy) International Journal of Urology. 2020.05; 27 (5): 471-472. ( 医中誌 )

  26. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation. Lower urinary tract symptoms. 2020.04; ( PubMed , DOI )

  27. Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: 筋層浸潤性膀胱癌の高齢患者への選択的4者併用膀胱温存療法の実行可能性と成績(Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer) International Journal of Urology. 2020.03; 27 (3): 236-243. ( 医中誌 )

  28. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.03; 27 (3): 236-243. ( PubMed , DOI )

  29. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y: Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed , DOI )

  30. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y: Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

  31. Tanaka Hajime, Fujii Yasuhisa: Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort INTERNATIONAL JOURNAL OF UROLOGY. 2020.03; 27 (3): 257. ( PubMed , DOI )

  32. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y: Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed , DOI )

  33. Tanaka Hajime, Fujii Yasuhisa: 「膀胱癌に対する根治的腹腔鏡下膀胱全摘術後の腫瘍学的成績と再発パターン　日本の多施設コホート」に対するDr.TanakaとDr.Fujiiによるエディトリアルコメント(Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort) International Journal of Urology. 2020.03; 27 (3): 257. ( 医中誌 )

  34. Tanaka H, Kijima T, Fujii Y: Bladder preservation therapy in muscle-invasive bladder cancer: Current evidence and future perspectives AME Medical Journal. 2020.02;

  35. Aguilar Palacios D, Caraballo ER, Tanaka H, Wang Y, Suk-Ouichai C, Ye Y, Lin L, Li J, Abouassaly R, Campbell SC: Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy. The Journal of urology. 2020.02; 101097JU0000000000000797. ( PubMed , DOI )

  36. Ye Yunlin, Tanaka Hajime, Wang Yanbo, Campbell Rebecca A., Aguilar Palacios Diego, DeWitt-Foy Molly E., Mahmood Furman A., Eltemamy Mohamed, Remer Erick M., Li Jianbo, Campbell Steven C.: Split renal function in patients with renal masses: utility of parenchymal volume analysis vs nuclear renal scans BJU INTERNATIONAL. 2020.02; 125 (5): 686-694. ( PubMed , DOI )

  37. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications. Clinical genitourinary cancer. 2020.02; ( PubMed , DOI )

  38. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer. European urology focus. 2020.01; ( PubMed , DOI )

  39. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications Clin Genitourin Cancer. 2020;

  40. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y: Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC) Clin Genitourin Cancer. 2020;

  41. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

  42. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y: Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

  43. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

  44. Ye Y*, Tanaka H*, Wang Y, Campbell RA, Aguilar Palacios D, Dewitt-Foy ME, Mahmood FA, Eltemamy M, Remer EM, Li J, Campbell SC: Split Renal Function in Patients with Renal Masses: Utility of Parenchymal Volume Analysis versus Nuclear Renal Scans BJU International. 2020; 125: 686-694. *Equal contribution. 2020;

  45. Tanaka H: Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association -Summary of the Revision Int J Urol. 2020. doi: 10.1111/iju.14314. 2020;

  46. Tanaka H: Editorial Comment to Retroperitoneal tumors: review of diagnosis and management Int J Urol. 2020; 27: 1071. 2020;

  47. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y: Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

  48. Tanaka H, Fujii Y: Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence Int J Urol. 2020. doi: 10.1111/iju.14419. 2020;

  49. Tanaka H, Fujii Y: Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns following laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort Int J Urol. 2020. doi: 10.1111/iju.14194. 2020;

  50. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y: Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

  51. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y: Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

  52. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y. : Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. Int J Urol. 2020; 27: 634-635. doi: 10.1111/iju.14249.. 2020;

  53. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. : Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. Int J Urol. 2020; 27: 471-472. doi: 10.1111/iju.14204.. 2020;

  54. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. : Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol. 2020 Jul;27(7):599-604. doi: 10.1111/iju.14251.. 2020;

  1. Toshiki Kijima, Hajime Tanaka, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019.12;

  2. SoichiroYoshida, TaroTakahara, Chikako Ishii, Yuki Arita, Yuma Waseda, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii: METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer 2019.12;

  3. Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y: Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clinical genitourinary cancer. 2019.12; ( PubMed , DOI )

  4. Yoshida S, Takahara T, Ishii C, Arita Y, Waseda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer. Clinical genitourinary cancer. 2019.12; ( PubMed , DOI )

  5. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y: Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). Clinical genitourinary cancer. 2019.11; ( PubMed , DOI )

  6. Rebecca A Campbell, Molly E DeWitt-Foy, Hajime Tanaka, Yun-Lin Ye, Yanbo Wang, Jeffrey Reese, Venkatesh Krishnamurthi, Wen Dong, Steven C Campbell: Functional Recovery From Prolonged Warm Ischemia: Compelling Case Scenarios. Urology. 2019.10; 132 22-27. ( PubMed , DOI )

  7. Yanbo Wang, Hajime Tanaka, Yunlin Ye, Xiaobo Ding, Ryan D Ward, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Erick M Remer, Steven C Campbell: The Complete Spectrum of Infiltrative Renal Masses: Clinical Characteristics and Prognostic Implications. Urology. 2019.08; 130 86-92. ( PubMed , DOI )

  8. Hajime Tanaka, Xiaobo Ding, Yunlin Ye, Yanbo Wang, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Ryan D Ward, Erick M Remer, Jianbo Li, Steven C Campbell: Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation. Eur Urol Oncol. 2019.08; ( PubMed , DOI )

  9. Kijima Toshiki, Tanaka Hajime, Koga Fumitaka, Masuda Hitoshi, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int. 2019.08; 124 (2): 242-250. ( PubMed , DOI )

  10. Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int J Urol. 2019.08; 26 (8): 820-826. ( PubMed , DOI )

  11. Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma International Journal of Urology. 2019.08; 26 (8): 820-826. ( 医中誌 )

  12. Yoshida Soichiro, Fujii Yasuhisa: Editorial Comment to Virtual reality of three-dimensional surgical field for surgical planning and intraoperative management. Int J Urol. 2019.07; ( PubMed , DOI )

  13. Yajima Shugo, Yoshida Soichiro, Takahara Taro, Arita Yuki, Tanaka Hiroshi, Waseda Yuma, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression. Eur Radiol. 2019.07; 29 (7): 3881-3888. ( PubMed , DOI )

  14. Chalairat Suk-Ouichai, Hajime Tanaka, Yanbo Wang, Jitao Wu, Yunlin Ye, Sevag Demirjian, Jianbo Li, Steven C Campbell: Renal Cancer Surgery in Patients without Preexisting Chronic Kidney Disease-Is There a Survival Benefit for Partial Nephrectomy? J. Urol.. 2019.06; 201 (6): 1088-1096. ( PubMed , DOI )

  15. Yoshida S, Takahara T, Arita Y, Ishii C, Uchida Y, Nakagawa K, Toda K, Sakamoto T, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y: Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor. International journal of radiation oncology, biology, physics. 2019.06; ( PubMed , DOI )

  16. Yoshida Soichiro, Maeda Takeshi, Yokoyama Minato, Toide Masahiro, Saito Kazutaka, Fujii Yasuhisa: Application of eye tracking as a user interface for urological surgery. Int J Urol. 2019.06; 26 (6): 680-681. ( PubMed , DOI )

  17. Yoshida Soichiro, Sugimoto Maki, Fukuda Shohei, Taniguchi Naoji, Saito Kazutaka, Fujii Yasuhisa: Mixed reality computed tomography-based surgical planning for partial nephrectomy using a head-mounted holographic computer. Int J Urol. 2019.06; 26 (6): 681-682. ( PubMed , DOI )

  18. Arita Yuki, Takahara Taro, Yoshida Soichiro, Kwee Thomas C, Yajima Shugo, Ishii Chikako, Ishii Ryota, Okuda Shigeo, Jinzaki Masahiro, Fujii Yasuhisa: Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. Invest Radiol. 2019.05; ( PubMed , DOI )

  19. Hajime Tanaka, Yanbo Wang, Chalairat Suk-Ouichai, Diego Aguilar Palacios, Elvis R Caraballo, Yunlin Ye, Erick M Remer, Jianbo Li, Robert Abouassaly, Steven C Campbell: Can We Predict Functional Outcomes after Partial Nephrectomy? J. Urol.. 2019.04; 201 (4): 693-701. ( PubMed , DOI )

  20. Elvis R Caraballo, Diego Aguilar Palacios, Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, Brian R Lane, Steven C Campbell: Open partial nephrectomy when a non-flank approach is required: indications and outcomes. World J Urol. 2019.03; 37 (3): 515-522. ( PubMed , DOI )

  21. Kijima Toshiki, Fukuda Shohei, Fukushima Hiroshi, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: Clinical outcomes of muscle-invasive bladder cancer patients with hydronephrosis treated with tetra-modality bladder sparing therapy incorporating consolidative partial cystectomy. JOURNAL OF CLINICAL ONCOLOGY. 2019.03; 37 (7):

  22. Jitao Wu, Chalairat Suk-Ouichai, Wen Dong, Zhiling Zhang, Hajime Tanaka, Yanbo Wang, Elvis Caraballo, Erick M Remer, Jianbo Li, Sudhir Isharwal, Robert Abouassaly, Steven C Campbell: Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors. Eur Urol Oncol. 2019.02; 2 (1): 97-103. ( PubMed , DOI )

  23. Araki Saori, Kijima Toshiki, Waseda Yuma, Komai Yoshinobu, Nakanishi Yasukazu, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Nakano Yujiro, Yoshimoto Takanobu, Uchida Tokujiro, Fujii Yasuhisa: Incidence and predictive factors of hypoglycemia after pheochromocytoma resection(和訳中) International Journal of Urology. 2019.02; 26 (2): 273-277. ( 医中誌 )

  24. Kawamura Naoko, Yokoyama Minato, Tanaka Hajime, Nakayama Takayuki, Yasuda Yosuke, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: 無阻血腎部分切除術後の急性腎障害と中期腎機能(Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy) International Journal of Urology. 2019.01; 26 (1): 113-118. ( 医中誌 )

  25. Hiroshi Watanabe, Hajime Tanaka, Yasuhisa Fujii, Makoto Kodama, Takumi Akashi, Tomoyuki Fujioka, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi: A case of immunoglobulin G4-related inflammatory pseudotumor mimicking renal cell carcinoma. Abdom Radiol (NY). 2019.01; ( PubMed , DOI )

  1. Yoshida Soichiro, Fujii Yasuhisa: High cell proliferation as a predictive factor for favorable response to chemoradiotherapy against bladder cancer CANCER SCIENCE. 2018.12; 109 1220.

  2. Saori Araki, Toshiki Kijima, Yuma Waseda, Yoshinobu Komai, Yasukazu Nakanishi, Sho Uehara, Yosuke Yasuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yujiro Nakano, Takanobu Yoshimoto, Tokujiro Uchida, Yasuhisa Fujii: Incidence and predictive factors of hypoglycemia after pheochromocytoma resection. Int. J. Urol.. 2018.11; ( PubMed , DOI )

  3. Ryan D Ward, Hajime Tanaka, Steven C Campbell, Erick M Remer: 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications. Radiographics. 2018.11; 38 (7): 2021-2033. ( PubMed , DOI )

  4. Soma Takahiko, Ishioka Junichiro, Tanaka Hajime, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: 造影CTとT2強調MRIによる脂肪に乏しい血管筋脂肪腫の診断を目的とした畳み込みニューラルネットワークアルゴリズムを用いたコンピュータ補助診断の可能性(Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging) International Journal of Urology. 2018.11; 25 (11): 978-979. ( 医中誌 )

  5. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  6. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  7. Yoshida Soichiro, Takahara Taro, Ishii Chikako, Nakagawa Keiko, Toda Kazuma, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa: Loco-regional radiotherapy targeting for oligo-progressive CRPC on the diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 358.

  8. Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Fujii Yasuhisa: MRI/ultrasound elastic fusion prostate biopsy : application to lesion - specific treatment of local therapy INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 167.

  9. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa: Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

  10. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  11. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa: Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

  12. Kawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y: Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urologia internationalis. 2018.10; 1-6. ( PubMed , DOI )

  13. Kawamura N, Yokoyama M, Tanaka H, Nakayama T, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y: Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. International journal of urology . 2018.09; ( PubMed , DOI )

  14. Nakayama T, Saito K, Kumagai J, Nakajima Y, Kijima T, Yoshida S, Kihara K, Fujii Y: Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Clinical genitourinary cancer. 2018.08; ( PubMed , DOI )

  15. Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii: Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. Int. J. Urol.. 2018.08; ( PubMed , DOI )

  16. Alice Crane, Chalairat Suk-Ouichai, Jack A Campbell, Elvis R Caraballo, Diego Aguilar Palacios, Hajime Tanaka, Steven C Campbell: Imprudent Utilization of Partial Nephrectomy. Urology. 2018.07; 117 22-26. ( PubMed , DOI )

  17. Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, J J H Zhang, Elvis Caraballo, Erick Remer, Jianbo Li, Sudhir Isharwal, Steven C Campbell: Tumor Contact Surface Area As a Predictor of Functional Outcomes After Standard Partial Nephrectomy: Utility and Limitations. Urology. 2018.06; 116 106-113. ( PubMed , DOI )

  18. Moriyama Shingo, Yoshida Soichiro, Tanaka Hajime, Tanaka Hiroshi, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma(和訳中) International Journal of Urology. 2018.06; 25 (6): 554-560. ( 医中誌 )

  19. Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int. J. Urol.. 2018.06; 25 (6): 554-560. ( PubMed , DOI )

  20. Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed , DOI )

  21. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Noboru Numao, Tomo Kimura, Kosei Kudo, Itsuo Kumazawa, Yasuhisa Fujii: Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm. BJU Int.. 2018.05; ( PubMed , DOI )

  22. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 IS-75. ( 医中誌 )

  23. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa: Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 IS-68. ( 医中誌 )

  24. Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Clinical outcomes of patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy. JOURNAL OF CLINICAL ONCOLOGY. 2018.02; 36 (6):

  25. Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii: Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol. Int.. 2018.01; 100 (1): 85-91. ( PubMed , DOI )

  1. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR Am J Roentgenol. 2017.08; 209 (2): W76-W84. ( PubMed , DOI )

  2. Soichiro Yoshida, Tsuneo Fukuyo, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery. Int. J. Urol.. 2017.08; 24 (8): 639-640. ( PubMed , DOI )

  3. Yoshida Soichiro, Fukuyo Tsuneo, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: 単孔式腹腔鏡下手術における手-目協調の改善のためのリアルタイム三次元画像の角度調整(Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery) International Journal of Urology. 2017.08; 24 (8): 639-640. ( 医中誌 )

  4. Yuma Waseda, Soichiro Yoshida, Taro Takahara, Thomas Christian Kwee, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer. J Magn Reson Imaging. 2017.08; 46 (2): 490-496. ( PubMed , DOI )

  5. Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clin Imaging. 2017.07; 44 121-126. ( PubMed , DOI )

  6. Hajime Tanaka, Yasuhisa Fujii, Hiroshi Tanaka, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Sho Uehara, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Junji Yonese, Kazunori Kihara: Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int. J. Urol.. 2017.07; 24 (7): 511-517. ( PubMed , DOI )

  7. Tanaka Hajime, Fujii Yasuhisa, Tanaka Hiroshi, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Uehara Sho, Numao Noboru, Yuasa Takeshi, Yamamoto Shinya, Masuda Hitoshi, Yonese Junji, Kihara Kazunori: 小径腎腫瘍中の脂肪成分の少ない腎血管筋脂肪腫診断のためのCTおよびMRIを用いたステップワイズアルゴリズム　開発および外的妥当性(Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation) International Journal of Urology. 2017.07; 24 (7): 511-517. ( 医中誌 )

  8. Tanaka Hajime, Fujii Yasuhisa, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori: 無阻血・無縫合法による低侵襲性腎部分切除術後のCTにおける仮性腎動脈瘤の非描出(Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques) International Journal of Urology. 2017.06; 24 (6): 472-473. ( 医中誌 )

  9. Soichiro Yoshida, Taro Takahara, Thomas C Kwee, Yuma Waseda, Shuichiro Kobayashi, Yasuhisa Fujii: DWI as an Imaging Biomarker for Bladder Cancer. AJR Am J Roentgenol. 2017.06; 208 (6): 1218-1228. ( PubMed , DOI )

  10. Hajime Tanaka, Yasuhisa Fujii, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara: Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques. Int. J. Urol.. 2017.06; 24 (6): 472-473. ( PubMed , DOI )

  11. Tanaka Hajime, Yoshida Soichiro, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: 免疫組織化学に基づいた分子的サブタイプ判定による筋層浸潤性膀胱癌における化学放射線療法に対する感受性の予測(Immunohistochemistry-based molecular subtypes predict therapeutic sensitivity of chemoradiotherapy in muscle-invasive bladder cancer) 日本泌尿器科学会総会. 2017.04; 105回 AOP11-07. ( 医中誌 )

  12. Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urol. Int.. 2017.03; 98 (3): 298-303. ( PubMed , DOI )

  1. Takayuki Nakayama, Noboru Numao, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: A novel interactive educational system in the operating room--the IE system. BMC Med Educ. 2016.02; 16 44. ( PubMed , DOI )

  2. Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Yasuyuki Sakai, Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Mitsuru Koizumi, Atsushi Kohno, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara: Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urol. Int.. 2016.01; 96 (1): 65-72. ( PubMed , DOI )

  1. Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Mizuaki Sakura, Hajime Tanaka, Tatsuro Hayashi, Sho Uehara, Yasushi Inoue, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Junji Yonese: Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1171-1178. ( PubMed , DOI )

  2. Takeshi Yuasa, Naoko Inoshita, Hajime Tanaka, Shinji Urakami, Shinya Yamamoto, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Yuichi Ishikawa, Junji Yonese: Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1198-1202. ( PubMed , DOI )

  3. Kenji Tanabe, Soichiro Yoshida, Fumitaka Koga, Masaharu Inoue, Shuichiro Kobayashi, Junichiro Ishioka, Tomoki Tamura, Emiko Sugawara, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, Kazunori Kihara: High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol. Clinical genitourinary cancer. 2015.08; 13 (4): e243-e251. ( PubMed , DOI )

  4. Soichiro Yoshida, Asami Sasaki, Chikage Sato, Mutsuko Yamazaki, Junya Takayasu, Naofumi Tanaka, Norie Okabayashi, Hiromi Hirano, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: A Novel Approach to Surgical Instructions for Scrub Nurses by Using See-Through-Type Head-Mounted Display. Comput Inform Nurs. 2015.08; 33 (8): 335-338. ( PubMed , DOI )

  5. Soichiro Yoshida, Kazunori Kihara, Tsuneo Fukuyo, Junichiro Ishioka, Kazutaka Saito, Yasuhisa Fujii: Novel three-dimensional image system for transurethral surgery. Int. J. Urol.. 2015.07; 22 (7): 714-715. ( PubMed , DOI )

  6. Soichiro Yoshida, Naotaka Fukui, Kazutaka Saito, Yasuhisa Fujii, Yukio Kageyama, Kazunori Kihara: Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery. Int. J. Urol.. 2015.05; 22 (5): 520-521. ( PubMed , DOI )

  7. Soichiro Yoshida, Masaya Ito, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Multitask Imaging Monitor for Surgical Navigation: Combination of Touchless Interface and Head-Mounted Display. Urologia internationalis. 2015.04; ( PubMed , DOI )

  8. Masaya Ito, Kazunori Kihara, Soichiro Yoshida, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii: Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display Urology Case Reports. 2015.03; 3 (2): 27-29. ( DOI )

  9. Inoue Masaharu, Kihara Kazunori, Yoshida Soichiro, Ito Masaya, Takeshita Hideki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa: A novel approach to patient self-monitoring of sonographic examinations using a head-mounted display. J Ultrasound Med. 2015.01; 34 (1): 29-35. ( PubMed , DOI )

  10. Manabu Tatokoro, Fumitaka Koga, Soichiro Yoshida, Kazunori Kihara: Heat shock protein 90 targeting therapy: state of the art and future perspective. EXCLI journal. 2015; 14 48-58. ( PubMed , DOI )

  1. Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori: Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma. Int J Urol. 2014.12; 21 (12): 1190-1200. ( PubMed , DOI )

  2. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa: A head-mounted display-based personal integrated-image monitoring system for transurethral resection of the prostate. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 644-649. ( PubMed , DOI )

  3. Fujii Yasuhisa, Kihara Kazunori, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka: A three-dimensional head-mounted display system (RoboSurgeon system) for gasless laparoendoscopic single-port partial cystectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 638-643. ( PubMed , DOI )

  4. Ishioka Junichiro, Kihara Kazunori, Higuchi Saori, Nakayama Takayuki, Takeshita Hideki, Yoshida Soichiro, Nakanishi Yasukazu, Kijima Toshiki, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa: New head-mounted display system applied to endoscopic management of upper urinary tract carcinomas. Int Braz J Urol. 2014.11; 40 (6): 842-845. ( PubMed )

  5. Junichiro Ishioka, Hitoshi Masuda, Toshiki Kijima, Manabu Tatokoro, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Yasuhisa Fujii, Yasuyuki Sakai, Chizuru Arisawa, Tetsuo Okuno, Katsuhi Nagahama, Shigeyoshi Kamata, Junji Yonese, Yukio Kageyama, Akira Noro, Shinji Morimoto, Toshihiko Tsujii, Satoshi Kitahara, Shuichi Gotoh, Kazunori Kihara: Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients. Anticancer Res.. 2014.10; 34 (10): 5683-5688. ( PubMed )

  6. Inoue Masaharu, Koga Fumitaka, Yoshida Soichiro, Tamura Tomoki, Fujii Yasuhisa, Ito Eisaku, Kihara Kazunori: Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. Int J Radiat Oncol Biol Phys. 2014.10; 90 (2): 303-311. ( PubMed , DOI )

  7. Uchida Yusuke, Yoshida Soichiro, Kobayashi S, Koga F, Ishioka J, Satoh S, Ishii C, Tanaka H, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K: Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer. The British journal of radiology. 2014.10; 87 (1042): 20130791. ( PubMed , DOI )

  8. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa: Instructive head-mounted display system: pointing device using a vision-based finger tracking technique applied to surgical education. Wideochir Inne Tech Malo Inwazyjne. 2014.09; 9 (3): 449-452. ( PubMed , DOI )

  9. Takeshita Hideki, Kihara Kazunori, Yoshida Soichiro, Higuchi Saori, Ito Masaya, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa: Clinical application of a modern high-definition head-mounted display in sonography. J Ultrasound Med. 2014.08; 33 (8): 1499-1504. ( PubMed , DOI )

  10. Nakayama Takayuki, Saito Kazutaka, Fujii Yasuhisa, Abe-Suzuki Shiho, Nakanishi Yasukazu, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Kihara Kazunori: Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy. Jpn J Clin Oncol. 2014.08; 44 (8): 756-761. ( PubMed , DOI )

  11. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Ishioka Junichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori: Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy. BJU Int. 2014.08; ( PubMed , DOI )

  12. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa: Head-Mounted Display for a Personal Integrated Image Monitoring System: Ureteral Stent Placement. Urol Int. 2014.08; ( PubMed , DOI )

  13. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Tanaka Hiroshi, Satoh Shiro, Fujii Yasuhisa, Kihara Kazunori: Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World J Radiol. 2014.06; 6 (6): 344-354. ( PubMed , DOI )

  14. Takeshita Hideki, Kawakami Satoru, Numao Noboru, Sakura Mizuaki, Tatokoro Manabu, Yamamoto Shinya, Kijima Toshiki, Komai Yoshinobu, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Fukui Iwao, Kihara Kazunori: Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method. BJU Int. 2014.04; ( PubMed , DOI )

  15. Bae Hyeyeol, Yoshida Soichiro, Matsuoka Yoh, Nakajima Hiroshi, Ito Eisaku, Tanaka Hiroshi, Oya Miyako, Nakayama Takayuki, Takeshita Hideki, Kijima Toshiki, Ishioka Junichiro, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Akashi Takumi, Fujii Yasuhisa, Kihara Kazunori: Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. Int Urol Nephrol. 2014.03; 46 (3): 555-561. ( PubMed , DOI )

  16. Ishioka Junichiro, Saito Kazutaka, Kijima Toshiki, Nakanishi Yasukazu, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Nagahama Katsuhi, Kamata Shigeyoshi, Sakura Mizuaki, Yonese Junji, Morimoto Shinji, Noro Akira, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Higashi Yotsuo, Kihara Kazunori: Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2014.02; ( PubMed , DOI )

  17. Mollapour Mehdi, Bourboulia Dimitra, Beebe Kristin, Woodford Mark R, Polier Sigrun, Hoang Anthony, Chelluri Raju, Li Yu, Guo Ailan, Lee Min-Jung, Fotooh-Abadi Elham, Khan Sahar, Prince Thomas, Miyajima Naoto, Yoshida Soichiro, Tsutsumi Shinji, Xu Wanping, Panaretou Barry, Stetler-Stevenson William G, Bratslavsky Gennady, Trepel Jane B, Prodromou Chrisostomos, Neckers Len: Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors. Molecular Cell. 2014.01; 53 (2): 317-329. ( PubMed , DOI )

  18. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori: Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol. 2014.01; 65 (1): 186-192. ( PubMed , DOI )

  19. Kobayashi Shuichiro, Koga Fumitaka, Kajino Kohei, Yoshita Soichiro, Ishii Chikako, Tanaka Hiroshi, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamada Tetsuo, Kihara Kazunori: Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging. 2014.01; 39 (1): 172-178. ( PubMed , DOI )

  20. Yachida Yuki, Yoshida Soichiro, Takeshita Hideki, Sawamura Chigusa, Tanaka Hiroshi, Satoh Shiro, Uchida Yusuke, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori: Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect? Urol Int. 2014; 93 (2): 170-175. ( PubMed , DOI )

  1. Miyajima Naoto, Tsutsumi Shinji, Sourbier Carole, Beebe Kristin, Mollapour Mehdi, Rivas Candy, Yoshida Soichiro, Trepel Jane B, Huang Ying, Tatokoro Manabu, Shinohara Nobuo, Nonomura Katsuya, Neckers Len: The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models. Cancer Research. 2013.12; 73 (23): 7022-7033. ( PubMed , DOI )

  2. Komai Yoshinobu, Numao Noboru, Yoshida Soichiro, Matsuoka Yoh, Nakanishi Yasukazu, Ishii Chikako, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol. 2013.09; 190 (3): 867-873. ( PubMed , DOI )

  3. Numao Noboru, Yoshida Soichiro, Komai Yoshinobu, Ishii Chikako, Kagawa Makoto, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol. 2013.08; 190 (2): 502-508. ( PubMed , DOI )

  4. Yoshida Soichiro, Kobayashi Shuichiro, Koga Fumitaka, Ishioka Junichiro, Ishii Chikako, Tanaka Hiroshi, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori: Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. Eur Radiol. 2013.08; 23 (8): 2206-2214. ( PubMed , DOI )

  5. Hiroshi Fukushima, Hitoshi Masuda, Minato Yokoyama, Manabu Tatokoro, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Jpn. J. Clin. Oncol.. 2013.07; 43 (7): 740-746. ( PubMed , DOI )

  6. Manabu Tatokoro, Kazunori Kihara, Hitoshi Masuda, Masaya Ito, Soichiro Yoshida, Toshiki Kijima, Minato Yokoyama, Kazutaka Saito, Fumitaka Koga, Satoru Kawakami, Yasuhisa Fujii: Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study. BMC Urol. 2013.07; 13 35. ( PubMed , DOI )

  7. Yoshida Soichiro, Tsutsumi Shinji, Muhlebach Guillaume, Sourbier Carole, Lee Min-Jung, Lee Sunmin, Vartholomaiou Evangelia, Tatokoro Manabu, Beebe Kristin, Miyajima Naoto, Mohney Robert P, Chen Yang, Hasumi Hisashi, Xu Wanping, Fukushima Hiroshi, Nakamura Ken, Koga Fumitaka, Kihara Kazunori, Trepel Jane, Picard Didier, Neckers Leonard: Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proceedings of the National Academy of Sciences of the United States of America. 2013.04; 110 (17): E1604-E1612. ( PubMed , DOI )

  8. Tanaka Hajime, Yuasa Takeshi, Fujii Yasuhisa, Sakura Mizuaki, Urakami Shinji, Yamamoto Shinya, Masuda Hitoshi, Fukui Iwao, Yonese Junji: First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era. Chemotherapy. 2013; 59 (6): 441-446. ( PubMed , DOI )

  9. Kijima Toshiki, Koga Fumitaka, Fujii Yasuhisa, Yoshida Soichiro, Tatokoro Manabu, Kihara Kazunori: Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1. PLoS One. 2013; 8 (5): e64615. ( PubMed , DOI )

  1. Iwai Aki, Bourboulia Dimitra, Mollapour Mehdi, Jensen-Taubman Sandra, Lee Sunmin, Donnelly Alison C, Yoshida Soichiro, Miyajima Naoto, Tsutsumi Shinji, Smith Armine K, Sun David, Wu Xiaolin, Blagg Brian S, Trepel Jane B, Stetler-Stevenson William G, Neckers Len: Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle. 2012.10; 11 (19): 3649-3655. ( PubMed , DOI )

  2. Kijima Toshiki, Masuda Hitoshi, Yoshida Soichiro, Tatokoro Manabu, Yokoyama Minato, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Kihara Kazunori: Antimicrobial prophylaxis is not necessary in clean category minimally invasive surgery for renal and adrenal tumors: a prospective study of 373 consecutive patients. Urology. 2012.09; 80 (3): 570-575. ( PubMed , DOI )

  3. Yuma Waseda, Hajime Tanaka, Kazuaki Nakagomi, Shuichi Goto, Akio Ido: A case of hereditary persistence of α-fetoprotein: diagnostic usefulness of the subfraction profile. Jpn. J. Clin. Oncol.. 2012.08; 42 (8): 767-769. ( PubMed , DOI )

  4. Tatokoro Manabu, Koga Fumitaka, Yoshida Soichiro, Kawakami Satoru, Fujii Yasuhisa, Neckers Len, Kihara Kazunori: Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer. 2012.08; 131 (4): 987-996. ( PubMed , DOI )

  5. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Ishii Chikako, Tanaka Hiroshi, Tanaka Hajime, Komai Yoshinobu, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2012.05; 83 (1): e21-e27. ( PubMed , DOI )

  6. Numao Noboru, Kawakami Satoru, Sakura Mizuaki, Yoshida Soichiro, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Ishikawa Yuichi, Fukui Iwao, Kihara Kazunori: Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU Int. 2012.03; 109 (5): 665-671. ( PubMed , DOI )

  7. Koga Fumitaka, Kihara Kazunori, Yoshida Soichiro, Yokoyama Minato, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru: Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU Int. 2012.03; 109 (6): 860-866. ( PubMed , DOI )

  8. Tsutsumi Shinji, Mollapour Mehdi, Prodromou Chrisostomos, Lee Chung-Tien, Panaretou Barry, Yoshida Soichiro, Mayer Matthias P, Neckers Leonard M: Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. Proceedings of the National Academy of Sciences of the United States of America. 2012.02; 109 (8): 2937-2942. ( PubMed , DOI )

  1. Yoshida Soichiro, Koga Fumitaka, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori: Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy. Cell Cycle. 2011.12; 10 (24): 4291-4299. ( PubMed , DOI )

  2. Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa, Ishii Chikako, Tanaka Hiroshi, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori: Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011.10; 18 (10): 727-730. ( PubMed , DOI )

  3. Kobayashi Shuichiro, Koga Fumitaka, Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Komai Yoshinobu, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. 2011.10; 21 (10): 2178-2186. ( PubMed , DOI )

  4. Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR Am J Roentgenol. 2011.01; 196 (1): 110-116. ( PubMed , DOI )

  5. Koga Fumitaka, Yoshida Soichiro, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori: ErbB2 and NFkappaB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer. PLoS One. 2011; 6 (11): e27616. ( PubMed , DOI )

  1. Yoshida Soichiro, Koga Fumitaka, Kawakami Satoru, Ishii Chikako, Tanaka Hiroshi, Numao Noboru, Sakai Yasuyuki, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori: Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology. 2010.02; 75 (2): 387-391. ( PubMed , DOI )

  1. Fukushima Hiroshi, Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa, Yoshida Soichiro, Ratovitski Edward, Trink Barry, Kihara Kazunori: Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway. Cancer Res. 2009.12; 69 (24): 9263-9270. ( PubMed , DOI )

  2. Koga Fumitaka, Kihara Kazunori, Fujii Yasuhisa, Yoshida Soichiro, Saito Kazutaka, Masuda Hitoshi, Kageyama Yukio, Kawakami Satoru: Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009.07; 104 (2): 189-194. ( PubMed , DOI )

  3. Yokoyama M, Fujii Y, Yoshida S, Saito K, Koga F, Masuda H, Kobayashi T, Kawakami S, Kihara K: Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. Int J Urol. 2009.01; 16 (1): 61-63. ( PubMed , DOI )

  1. Koga F, Yoshida S, Kawakami S, Kageyama Y, Yokoyama M, Saito K, Fujii Y, Kobayashi T, Kihara K: Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008.08; 72 (2): 384-388. ( PubMed , DOI )

  2. Yoshida S, Fujii Y, Yokoyama M, Ishii C, Saito K, Koga F, Masuda H, Kobayashi T, Kawakami S, Kihara K: Female urethral diverticular abscess clearly depicted by diffusion-weighted magnetic resonance imaging. Int J Urol. 2008.05; 15 (5): 460-461. ( PubMed , DOI )

  3. Yoshida S, Saito K, Koga F, Yokoyama M, Kageyama Y, Masuda H, Kobayashi T, Kawakami S, Kihara K: C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 2008.04; 101 (8): 978-981. ( PubMed , DOI )

  4. Masuda Hitoshi, Kihara Kazunori, Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Chancellor Michael B, de Groat William C, Yoshimura Naoki: Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU international. 2008.03; 101 (6): 775-780. ( PubMed , DOI )

  5. Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Saito Kazutaka, Kawakami Satoru, Kihara Kazunori: Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging. International journal of urology : official journal of the Japanese Urological Association. 2008.02; 15 (2): 140-143. ( PubMed , DOI )

  1. Yoshida Soichiro, Hayashi Tetsuo, Morozumi Makoto, Osada Hisato, Honda Norinari, Yamada Takumi: Three-dimensional assessment of urinary stone on non-contrast helical computed tomography as the predictor of stonestreet formation after extracorporeal shock wave lithotripsy for stones smaller than 20 mm. International journal of urology : official journal of the Japanese Urological Association. 2007.07; 14 (7): 665-667. ( PubMed , DOI )

  2. Yoshida S, Masuda H, Yokoyama M, Kobayashi T, Kawakami S, Kihara K: Absence of prophylactic antibiotics in minimum incision endoscopic urological surgery (MEUS) of adrenal and renal tumors. Int J Urol. 2007.05; 14 (5): 384-387. ( PubMed , DOI )

  3. Yoshida Soichiro, Hayashi Tetsuo, Okada Takemichi, Osada Hisato, Honda Norinari, Yamada Takumi: Discrimination between ureteral stent and stone by non-contrast helical computed tomography in the clinical setting. International journal of urology : official journal of the Japanese Urological Association. 2007.02; 14 (2): 171-173. ( PubMed , DOI )

  1. Yoshida Soichiro, Hayashi Tetsuo, Ikeda Jun, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Okada Takemichi, Osada Hisato, Honda Norinari, Yamada Takumi: Role of volume and attenuation value histogram of urinary stone on noncontrast helical computed tomography as predictor of fragility by extracorporeal shock wave lithotripsy. Urology. 2006.07; 68 (1): 33-37. ( PubMed , DOI )

  2. Hayashi Tetsuo, Yoshida Soichiro, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Yamada Takumi: Asthenospermia in hay fever patients improved by stopping treatment with histamine H1 receptor antagonists. Int J Urol. 2006.07; 13 (7): 1028-1030. ( PubMed , DOI )

  3. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Futatsubashi Masami, Torizuka Tatsuo: C-choline positron emission tomography in bladder cancer: report of four cases. International journal of urology : official journal of the Japanese Urological Association. 2006.06; 13 (6): 829-831. ( PubMed , DOI )

  4. Hayashi Tetsuo, Yoshida Soichiro, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Yamada Takumi: HtrA2 is up-regulated in the rat testis after experimental cryptorchidism. International journal of urology : official journal of the Japanese Urological Association. 2006.02; 13 (2): 157-164. ( PubMed , DOI )

  5. Yoshida Soichiro, Hayashi Tetsuo, Ishii Nobuyuki, Yoshinaga Atsushi, Ohno Rena, Terao Toshiya, Watanabe Toru, Yamada Takumi, Osada Hisato: Bilateral renal angiomyolipoma coexistent with pulmonary lymphangioleiomyomatosis and tuberous sclerosis. International urology and nephrology. 2006; 38 (3-4): 413-415. ( PubMed , DOI )

  1. Hayashi Tetsuo, Yoshida Soichiro, Yoshinaga Atushi, Ohno Rena, Ishii Nobuyuki, Yamada Takumi: Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin. Scandinavian journal of urology and nephrology. 2005; 39 (5): 431-432. ( PubMed , DOI )

  2. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Futatsubashi Masami, Torizuka Tatsuo: 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging. Urologia internationalis. 2005; 74 (3): 214-220. ( PubMed , DOI )

  1. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Ozawa Takachika: Cystic hamartoma of the renal pelvis. International journal of urology : official journal of the Japanese Urological Association. 2004.08; 11 (8): 653-655. ( PubMed , DOI )

  2. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Kobayashi Satoshi: Malignant pheochromocytoma of the urinary bladder: effectiveness of radiotherapy in conjunction with chemotherapy. International journal of urology : official journal of the Japanese Urological Association. 2004.03; 11 (3): 175-177. ( PubMed )

  3. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi: Abscess formation in the prevesical space and bilateral thigh muscles secondary to osteomyelitis of the pubis--basis of the anatomy between the prevesical space and femoral sheath. Scandinavian journal of urology and nephrology. 2004; 38 (5): 440-441. ( PubMed , DOI )

  1. 田中 一、藤井 靖久: 【泌尿器科腫瘍の監視療法のすべて】小径腎癌に対する監視療法 泌尿器外科. 2023.11; 36 (11): 1190-1195. ( 医中誌 )

  2. Kaneko Hiroki, Fujiwara Motohiro, Tanaka Hajime, Kimura Koichiro, Yoshida Soichiro, Fujii Yasuhisa: Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma INTERNATIONAL JOURNAL OF UROLOGY. 2023.07; ( DOI )

  3. 福田 翔平, 田中 一, 藤井 靖久: 【腎癌薬物療法を極める】イピリムマブ+ニボルマブ併用療法を極める 泌尿器外科. 2023.07; 36 (7): 599-605. ( 医中誌 )

  4. Soma Takahiko, Fukuda Shohei, Matsuyama Yusuke, Ikeda Riko, Inoue Masaharu, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujiwara Takeo, Kageyama Yukio, Fujii Yasuhisa: Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy INTERNATIONAL JOURNAL OF UROLOGY. 2023.06; 30 (6): 532-538. ( PubMed , DOI )

  5. Fujiwara Motohiro, Yoshida Soichiro, Takahara Taro, Soma Takahiko, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa: Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naive prostate Cancer CLINICAL & EXPERIMENTAL METASTASIS. 2023.04; 40 (2): 187-195. ( PubMed , DOI )

  6. 田中 一: 【どこまで変わるの?　腎細胞癌診療の進歩】手術療法　Cytoreductive nephrectomyの現状 臨床泌尿器科. 2023.04; 77 (5): 348-354. ( 医中誌 )

  7. 石川 雄大, 上原 翔, 中村 祐基, 内田 裕將, 福田 翔平, 田中 一, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久: アミノレブリン酸使用下における経尿道的膀胱腫瘍切除　術中低血圧の頻度と予測因子の検討 日本腎泌尿器疾患予防医学研究会誌. 2023.03; 31 (1): 47-49. ( 医中誌 )

  8. Yoshida Soichiro, Takahara Taro, Arita Yuki, Ito Masaya, Hayakawa Sara, Oguchi Tomohiko, Komai Yoshinobu, Numao Noboru, Yuasa Takeshi, Inoue Masaharu, Ushijima Hiroki, Kudo Shigehiro, Shimano Yasumasa, Nakamura Yuki, Uchida Yusuke, Uehara Sho, Tanaka Hajime, Yaegashi Hiroshi, Izumi Kouji, Yokoyama Minato, Matsuoka Yoh, Yoshioka Yasuo, Konishi Koji, Nakanishi Katsuyuki, Nagahara Akira, Hirakawa Akihiro, Koike Ryuji, Koga Fumitaka, Nishimura Kazuo, Mizokami Atsushi, Yonese Junji, Kageyama Yukio, Yoshimura Ryoichi, Fujii Yasuhisa: A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL) BMC UROLOGY. 2023.03; 23 (1): 33. ( PubMed , DOI )

  9. Yoshida Soichiro, Takahara Taro, Tanaka Hajime, Yokoyama Minato, Yoshimura Ryoichi, Fujii Yasuhisa: The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer INTERNATIONAL JOURNAL OF UROLOGY. 2023.03; ( PubMed , DOI )

  10. Chen Wei, Yokoyama Minato, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Nonomura Norio, Fujii Yasuhisa: Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study INTERNATIONAL JOURNAL OF UROLOGY. 2023.03; 30 (3): 258-263. ( PubMed , DOI )

  11. 田中 一, 藤井 靖久: 【最新版!　筋層浸潤性膀胱癌の診断と治療-アンメットニーズはどこまで埋まったか】治療　筋層浸潤性膀胱癌に対する膀胱温存療法 臨床泌尿器科. 2023.03; 77 (3): 250-256. ( 医中誌 )

  12. 田中 一: 【IO時代における転移性腎癌に対する局所治療を考える】腫瘍減量腎摘除　upfront CNの適応は? 泌尿器外科. 2023.02; 36 (2): 99-105. ( 医中誌 )

  1. 田中 一, 藤井 靖久: 高齢者における膀胱癌の治療 日本老年泌尿器科学会誌. 2022.12; 35 (2): 53-63. ( 医中誌 )

  2. 横山 みなと, 安田 庸輔, 上原 翔, 田中 一, 吉田 宗一郎, 松岡 陽, 藤井 靖久: ミニマム創内視鏡下無阻血腎部分切除　何を見るか,何を見せるか 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2022.12; 14 65-69. ( 医中誌 )

  3. 三宅 秀明, 井上 貴博, 白石 晃司, 木村 高弘, 田中 一, 堀田 記世彦: 査読委員の確保と教育 日本泌尿器科学会雑誌. 2022.11; 113 (Suppl.): S150-S156. ( 医中誌 )

  4. 田中 一, 藤井 靖久: 【おさえておくべき、Clinical trial!-進行性尿路上皮癌編-】CheckMate 274試験 泌尿器外科. 2022.07; 35 (7): 588-595. ( 医中誌 )

  5. 山本 真也, 米瀬 淳二, 増田 均, 浦上 慎司, 田中 一, 福井 巌: 片側海綿体神経温存前立腺全摘除術における術後陰茎リハビリテーションの勃起機能回復効果　タダラフィルを使用した前向き無作為化比較試験 日本性機能学会雑誌. 2022.06; 37 (1): 1-7. ( 医中誌 )

  6. 田中 一, 藤井 靖久: 【泌尿器系がんの診断と治療】膀胱がんの診断と治療　新規薬物治療が保険承認となるなど膀胱がんの診断・治療は大きく変化 ライフライン21がんの先進医療. 2022.04; 45 20-26. ( 医中誌 )

  7. 田中 一, 松岡 陽, 藤井 靖久: 【専門性と多様性を両立させる! 泌尿器科外来ベストNAVI】腫瘍外来　腎細胞癌 臨床泌尿器科. 2022.04; 76 (4): 144-147. ( 医中誌 )

  8. 田中 一, 松岡 陽, 藤井 靖久. : 専門性と多様性を両立させる! 泌尿器科外来ベストNAVI. 腎細胞癌 臨床泌尿器科. 2022;

  9. 田中 一, 藤井 靖久.: 究極の集学的治療：膀胱温存療法 泌尿器外科. 2022;

  10. 田中 一: ニボルマブ（＋イピリムマブ）はこのように使用する！ 泌尿器外科. 2022;

  11. 田中 一, 藤井 靖久: そもそも腎部分切除が正しいのか？腎摘の適応と意義 泌尿器外科. 2022;

  12. 田中 一, 藤井 靖久: 膀胱がんの診断と治療 ライフライン21 がんの先進医療. 2022;

  13. 田中 一, 藤井 靖久: CheckMate 274試験 泌尿器外科. 2022;

  1. 田中 一, 藤井 靖久: 【腎疾患治療薬update】(第3章)泌尿器科疾患　腎癌・腎盂癌(尿路上皮癌)　免疫チェックポイント阻害薬(抗PD-1抗体、抗PD-L1抗体、抗CTLA-4抗体) 腎と透析. 2021.08; 91 (増刊): 585-590. ( 医中誌 )

  2. 田中 一, 藤井 靖久: 【高齢者尿路上皮がん治療のコントロバシー-どこまで、どのように治療するか?-】高齢者における膀胱全摘除術の適応・術式選択と代替療法 泌尿器外科. 2021.06; 34 (6): 551-556. ( 医中誌 )

  3. 中村 祐基, 吉田 宗一郎: 【泌尿器科当直医マニュアル】総論　緊急時のCT検査の基礎的知識 臨床泌尿器科. 2021.04; 75 (4): 023-027. ( 医中誌 )

  4. 中村 祐基, 吉田 宗一郎: 【泌尿器科当直医マニュアル】総論　緊急時の超音波検査の基礎的知識 臨床泌尿器科. 2021.04; 75 (4): 018-022. ( 医中誌 )

  5. 田中 一, 藤井 靖久: 【ロボット支援手術時代における開創手術の役割と極意】下大静脈腫瘍塞栓切除を伴う根治的腎摘除 泌尿器外科. 2021.02; 34 (2): 119-125. ( 医中誌 )

  6. 有田 祐起, 奥田 茂男, 吉田 宗一郎, 八木 文子, 秋田 大宇, 高原 太郎, 藤井 靖久, 陣崎 雅弘: "今期保険収載"全身MRIによる進行前立腺癌の病勢評価　MET-RADS-Pに基づく標準撮像プロトコルおよび読影評価の実際 INNERVISION. 2021.01; 36 (2): 76-80. ( 医中誌 )

  1. 福田 翔平, 上原 翔, 田中 一, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久: 3D内視鏡下手術(ミニマム創内視鏡下手術、ロボット支援腹腔鏡下手術)における眼鏡型ウェアラブル3Dディスプレイの使用経験 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2020.12; 12 7-9. ( 医中誌 )

  2. 横山 みなと, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久: 2cmのシングルポートから行うミニマム創内視鏡下副腎摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2020.12; 12 77-83. ( 医中誌 )

  3. 木島 敏樹, 木原 和徳, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久: 筋層浸潤膀胱癌に対する4者併用膀胱温存療法(TUR+低用量化学放射線療法+ミニマム創内視鏡下膀胱部分切除)　水腎症症例に対する膀胱部分切除+尿管膀胱新吻合 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2020.12; 12 113-118. ( 医中誌 )

  4. 横山 みなと, 森山 真吾, 内田 裕將, 戸出 真宏, 福島 啓司, 上原 翔, 安田 庸輔, 田中 一, 吉田 宗一郎, 松岡 陽, 藤井 靖久: 前立腺全摘除後、救済放射線治療歴のある重症尿失禁患者に対する人工尿道括約筋植込後の下部尿路症状および尿失禁の変化 日本排尿機能学会誌. 2020.10; 31 (1): 262. ( 医中誌 )

  5. 田中 一, 加藤 廉平, 佐塚 智和, 小島 崇宏, 濱本 周造, 山名 一寿, 山本 勇人, 杉野 友亮, 中井川 昇, 加峰 弘毅, 藤森 健夫, 小原 航: 未治療転移性腎細胞癌に対するNIV+IPI併用療法(J-cardinal study)　1年follow-up解析 日本癌治療学会学術集会抄録集. 2020.10; 58回 O35-6. ( 医中誌 )

  6. 山名 一寿, 加藤 廉平, 佐塚 智和, 小島 崇宏, 田中 一, 濱本 周造, 山本 勇人, 杉野 友亮, 中井川 昇, 加峰 弘毅, 藤森 健夫, 小原 航: 未治療mRCCのNIV+IPI実臨床観察研究(J-cardinal study)　1年follow-up subgroup解析 日本癌治療学会学術集会抄録集. 2020.10; 58回 O35-2. ( 医中誌 )

  7. 吉田 宗一郎, 藤井 靖久: 【骨転移の画像診断】骨転移を伴う前立腺癌の臨床と画像診断 臨床画像. 2020.08; 36 (8): 903-910. ( 医中誌 )

  8. 吉田 宗一郎: 【Q&Aでまとめる! 予後予測・治療効果予測の画像検査】腎臓・泌尿器・生殖器　去勢抵抗性前立腺癌の予後・治療効果を予測する画像検査法は何か? 臨床放射線. 2020.08; 65 (8): 927-935. ( 医中誌 )

  9. 吉田 宗一郎, 藤井 靖久: 【オリゴ転移・オリゴ再発前立腺癌を巡る諸問題】去勢抵抗性前立腺癌:oligoprogressive diseaseに対する局所治療 泌尿器外科. 2020.07; 33 (7): 959-963. ( 医中誌 )

  10. 吉田 宗一郎: 【これ一冊でパーフェクト!!泌尿器科悪性腫瘍のエビデンス】腎癌　非転移性腎癌　Bosniak III/IVに対する方針 泌尿器外科. 2020.04; 33 (特別号): 29-33. ( 医中誌 )

  11. 田中 一: 【これ一冊でパーフェクト!!泌尿器科悪性腫瘍のエビデンス】腎癌　転移性腎癌　転移病変に対する局所治療 泌尿器外科. 2020.04; 33 (特別号): 66-71. ( 医中誌 )

  12. 田中 一, 木島 敏樹, 藤井 靖久: 【泌尿器がんの新しい放射線治療戦略】尿路上皮(膀胱)がん　浸潤性膀胱がんに対する低用量化学放射線療法を用いた4者併用膀胱温存療法(TeMT) 泌尿器科. 2020.04; 11 (4): 392-399. ( 医中誌 )

  13. 田中 一: 【これ一冊でパーフェクト!!泌尿器科悪性腫瘍のエビデンス】腎癌　非転移性腎癌　Active surveillance 泌尿器外科. 2020.04; 33 (特別号): 14-18. ( 医中誌 )

  14. 田中 一: 【これ一冊でパーフェクト!!泌尿器科悪性腫瘍のエビデンス】腎癌　非転移性腎癌　Ablation 泌尿器外科. 2020.04; 33 (特別号): 19-23. ( 医中誌 )

  15. 田中 一, 藤井 靖久: 【腎がんに対する外科治療の現状と展望】進行腎がんに対する術前薬物療法の現状と問題点 泌尿器科. 2020.03; 11 (3): 298-304. ( 医中誌 )

  16. 松本 峻弥, 森山 真吾, 本村 鷹多朗, 木島 敏樹, 内田 裕將, 戸出 真宏, 福田 翔平, 福島 啓司, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 山本 正英, 齋藤 一隆, 三浦 修, 藤井 靖久: Pembrolizumab投与で異なる機序による2度の血小板減少を来たした転移性膀胱癌の1例 泌尿器外科. 2020.02; 33 (2): 204. ( 医中誌 )

  17. 田中 一, 吉田 宗一郎: 【泌尿器科癌のリンパ節郭清:最新エビデンスとエキスパートの実践】泌尿器癌リンパ節転移の画像診断 泌尿器外科. 2020.01; 33 (1): 3-9. ( 医中誌 )

  18. 吉田 宗一郎, 藤井 靖久: 尿路上皮癌のimaging biomarkerとしての拡散強調MRI Japanese Journal of Diagnostic Imaging. 2020.01; 38 (1): 81. ( 医中誌 )

  19. 田中 一: 【これ一冊でパーフェクト!!泌尿器科悪性腫瘍のエビデンス】腎癌　非転移性腎癌　Active surveillance 泌尿器外科. 2020;

  20. 田中 一: 【これ一冊でパーフェクト!!泌尿器科悪性腫瘍のエビデンス】腎癌　非転移性腎癌　Ablation 泌尿器外科. 2020;

  21. 田中 一, 木島 敏樹, 藤井 靖久: 【泌尿器がんの新しい放射線治療戦略】浸潤性膀胱がんに対する低用量化学放射線療法を用いた4者併用膀胱温存療法 (TeMT) 泌尿器外科. 2020;

  22. 田中 一, 藤井 靖久: 【腎がんに対する外科治療の現状と展望】進行腎がんに対する術前薬物療法の現状と問題点 泌尿器外科. 2020;

  23. 田中 一, 吉田 宗一郎: 【泌尿器科癌のリンパ節郭清：最新エビデンスとエキスパートの実践】泌尿器科癌リンパ節転移の画像診断 泌尿器外科. 2020;

  24. 吉田　宗一郎: 【Q&Aでまとめる! 予後予測・治療効果予測の画像検査】腎臓・泌尿器・生殖器　去勢抵抗性前立腺癌の予後・治療効果を予測する画像検査法は何か?(Q&A/特集) 臨床放射線. 2020;

  25. 吉田 宗一郎, 藤井 靖久. : 【オリゴ転移・オリゴ再発前立腺癌を巡る諸問題】去勢抵抗性前立腺癌:oligoprogressive diseaseに対する局所治療 泌尿器外科. 2020;

  26. 吉田 宗一郎, 藤井 靖久: 【骨転移の画像診断】骨転移を伴う前立腺癌の臨床と画像診断 臨床画像. 2020;

  27. 吉田 宗一郎: 【これ一冊でパーフェクト!!泌尿器科悪性腫瘍のエビデンス】腎癌　非転移性腎癌　Bosniak III/IVに対する方針 泌尿器外科. 2020;

  1. 横山 みなと, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久: 2cmのシングルポートから行うミニマム創内視鏡下副腎摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2019.12; 11 (2): 46. ( 医中誌 )

  2. 福田 翔平, 横山 みなと, 上原 翔, 田中 一, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久: 3D内視鏡下手術(ミニマム創内視鏡下手術、ロボット支援腹腔鏡下手術)における眼鏡型ウェアラブル3Dディスプレイの使用経験 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2019.12; 11 (2): 14-15. ( 医中誌 )

  3. 吉田 宗一郎, 谷口 直嗣, 伊藤 健暉, 森山 真吾, 上原 翔, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久: 術前シミュレーション、患者への術式説明および医学生の超音波実習へのextended reality技術の応用 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2019.12; 11 (2): 54-55. ( 医中誌 )

  4. 木島 敏樹, 木原 和徳, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久: 筋層浸潤膀胱癌に対する4者併用膀胱温存療法(TUR+低用量化学放射線療法+ミニマム創内視鏡下膀胱部分切除)　水腎症症例に対する膀胱部分切除+尿管膀胱新吻合 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2019.12; 11 (2): 60-62. ( 医中誌 )

  5. 吉田 宗一郎, 高原 太郎, 藤井 靖久: 【前立腺癌MRI診断の最先端】DWIBS法による前立腺癌の治療効果判定 泌尿器外科. 2019.10; 32 (10): 1263-1269. ( 医中誌 )

  6. 藤井 靖久, 吉田 宗一郎: 前立腺腫瘍学の変遷からひもとく進行期前立腺癌治療に求めるもの　進行期前立腺癌の根治は目指せるか?　去勢抵抗性前立腺癌に対するpersonalized medicineの確立に向けて　全身MRI(DWBS法)を用いた活動性病変の同定とoligo-progressive diseaseに対する標的放射線療法 西日本泌尿器科. 2019.10; 81 (増刊): 97. ( 医中誌 )

  7. 横山 みなと, 射場 朝子, 岡安 健, 野田 一真, 宮崎 緑, 福島 啓司, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久: 排尿ケアチームが介入した維持血液透析患者の2例 日本排尿機能学会誌. 2019.09; 30 (1): 304. ( 医中誌 )

  8. 木島 敏樹, 田中 一, 藤井 靖久: 【どこまでできる?機能温存・泌尿器がん手術】究極の機能温存　筋層浸潤膀胱癌に対する4者併用膀胱温存療法 泌尿器外科. 2019.09; 32 (9): 1161-1166. ( 医中誌 )

  9. 石岡 淳一郎, 相馬 崇彦, 田中 一, 上原 翔, 安田 庸輔, 木島 敏樹[上原], 吉田 宗一郎, 横山 みなと, 松岡 陽, 齋藤 一隆, 藤井 靖久: 畳み込みニューラルネットワークを用いたfat-poor AMLの画像鑑別診断 泌尿器外科. 2019.06; 32 (臨増): 737. ( 医中誌 )

  10. 福田 翔平, 齋藤 一隆, 安田 庸輔, 田中 一, Ryan Stephen, Bindayi Ahmet, Cotta Brittney, Patel Sunil, Derweesh Ithaar, 木原 和徳, 藤井 靖久: 限局性腎癌における予後予測因子としての術前C反応性蛋白(CRP)の人種差についての検討 泌尿器外科. 2019.06; 32 (臨増): 737. ( 医中誌 )

  11. 吉田 宗一郎, 小林 正貴, 内田 裕將, 田中 一, 高原 太郎, 藤井 靖久: 尿路上皮癌におけるリンパ郭清の意義　機能的画像診断による尿路上皮癌リンパ節転移巣評価　PET/CTおよびDWIBSの活用 日本泌尿器科学会総会. 2019.04; 107回 SY25-5. ( 医中誌 )

  12. 吉田 宗一郎, 高原 太郎, 石井 千佳子, 有田 祐起, 藤井 靖久: 【全身拡散強調画像の歴史と発展】DWIBSを使用した去勢抵抗性前立腺癌に対する新規アプローチ 臨床放射線. 2019.03; 64 (3): 227-233. ( 医中誌 )

  13. 福田 悠一, 上原 翔, 田中 一, 相馬 貴彦, 矢嶋 習吾, 戸出 真宏, 福田 翔平, 早稲田 悠馬, 安田 庸輔, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 腎細胞癌との鑑別が困難な腎腫瘤を形成したMikulicz病の1例 泌尿器外科. 2019.02; 32 (2): 198. ( 医中誌 )

  14. 泉 敬太, 早稲田 悠馬, 中山 貴之, 田中 一, 川村 尚子, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 右腎癌下大静脈腫瘍塞栓及び膵転移切除後、多発転移再発に対する集学的治療により完全寛解を得た1例 泌尿器外科. 2019.02; 32 (2): 188. ( 医中誌 )

  15. 矢嶋 習吾, 吉田 宗一郎, 高原 太郎, 泉 敬太, 早稲田 悠馬, 中山 貴之, 田中 一, 川村 尚子, 井上 雅晴, 伊藤 将也, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 斎藤 一隆, 木原 和徳, 藤井 靖久: 全身拡散強調MRIが活動性骨転移病巣の同定と治療効果の判定に有用であった去勢抵抗性前立腺癌の2例 泌尿器外科. 2019.02; 32 (2): 193. ( 医中誌 )

  16. 中村 祐基, 中山 貴之, 吉田 宗一郎, 藤原 基裕, 早稲田 悠馬, 田中 一, 川村 尚子, 井上 雅晴, 伊藤 将也, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 大井 啓司, 田邉 稔, 井上 芳徳, 藤井 靖久, 木原 和徳: IFN-αを中心とした術前療法(I-CCA療法)により開心術を回避しえた、心房内進展を伴う左腎癌の1例 泌尿器外科. 2019.02; 32 (2): 185. ( 医中誌 )

  1. 藤井 靖久, 木原 和徳, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆: 筋層浸潤膀胱癌に対する膀胱温存療法　ガスレス・シングルポート・ロボサージャン(先端型ミニマム創内視鏡下)膀胱部分切除を組み込んだTMDUプロトコール 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2018.08; 10 (1): 129-134. ( 医中誌 )

  2. 井上 雅晴, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: ミニマム創内視鏡下清潔手術における予防的抗菌薬無投与 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2018.08; 10 (1): 61-64. ( 医中誌 )

  3. 横山 みなと, 田中 一, 井上 雅晴, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: ガスレス・シングルポート・ロボサージャン腎部分切除　治療選択、合併症対策について 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2018.08; 10 (1): 13-16. ( 医中誌 )

  4. 木島 敏樹, 齋藤 一隆, 上原 翔, 安田 庸輔, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 木原 和徳, 藤井 靖久: ガスレス・シングルポート・ロボサージャン男性膀胱全摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2018.08; 10 (1): 125-128. ( 医中誌 )

  5. 田中 一, 藤井 靖久, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳: 無阻血無縫合腎部分切除後に仮性動脈瘤は発生するか　術後早期造影CTを用いた検討 腎癌研究会会報. 2018.07; (48): 101. ( 医中誌 )

  6. 田邉 健児, 齋藤 一隆, 中込 一彰, 有澤 千鶴, 塚本 哲朗, 奥野 哲男, 長浜 克志, 野呂 彰, 森本 信二, 北原 聡史, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 木原 和徳, 藤井 靖久: 限局性淡明腎細胞癌患者における根治的腎摘除後再発部位の継時的変化 腎癌研究会会報. 2018.07; (48): 51. ( 医中誌 )

  7. 早稲田 悠馬, 齋藤 一隆, 石川 雄大, 田中 一, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 川野 圭三, 松岡 陽, 森本 信二, 木原 和徳, 藤井 靖久: 造影CTの患側・健側腎皮質CT値割合を用いた腎尿管全摘除後の残腎機能予測　核医学検査との比較および外部検証 泌尿器外科. 2018.06; 31 (臨増): 831. ( 医中誌 )

  8. 矢嶋 習吾, 吉田 宗一郎, 田中 一, 井上 雅晴, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 斎藤 一隆, 木原 和徳, 藤井 靖久: inchworm sign陰性のpT1膀胱癌は再発時進展のリスクが高い 泌尿器外科. 2018.06; 31 (臨増): 832. ( 医中誌 )

  9. 木島 敏樹, 田中 一, 井上 雅晴, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 筋層浸潤性膀胱癌に対する低用量化学放射線療法および膀胱部分切除による膀胱温存療法の治療成績　初発例・進展例の比較 泌尿器外科. 2018.06; 31 (臨増): 832. ( 医中誌 )

  10. 福田 悠一, 木島 敏樹, 田中 一, 井上 雅晴, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 積極的な外科的切除により完全寛解を得た、副腎皮質癌局所再発の2例 泌尿器外科. 2018.06; 31 (臨増): 817. ( 医中誌 )

  11. 相馬 貴彦, 横山 みなと, 内田 裕將, 井上 雅晴, 田中 一, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 膀胱全摘除および腸間膜リンパ節郭清にて5年の長期生存を得ている、拡大膀胱部に発生しリンパ節転移を来した扁平上皮癌の1例 泌尿器外科. 2018.06; 31 (臨増): 850. ( 医中誌 )

  12. 田辺 健児, 吉田 宗一郎, 松岡 陽, 上原 翔, 安田 庸輔, 田中 一, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 齋藤 一隆, 木原 和徳, 藤井 靖久: UroNav前立腺生検システムによる系統生検ガイドの有用性検討　前立腺ファントムを用いた解析 日本泌尿器科学会総会. 2018.04; 106回 PP3-179. ( 医中誌 )

  13. 福田 悠一, 田中 一, 安田 庸輔, 上原 翔, 吉田 宗一郎, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 当院における小径腎腫瘍に対する腎腫瘍生検 日本泌尿器科学会総会. 2018.04; 106回 PP3-022. ( 医中誌 )

  14. 千野 航平, 吉田 宗一郎, 田中 宏, 矢島 習吾, 田中 一, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 筋層浸潤性膀胱癌に対する膀胱温存療法における拡散強調MRI　inchworm signの意義 日本泌尿器科学会総会. 2018.04; 106回 PP1-054. ( 医中誌 )

  15. 安田 庸輔, 田中 一, 藤井 靖久: 腎小腫瘤に対するアプローチ 小径腎腫瘤に対する腎腫瘤生検 日本泌尿器科学会総会. 2018.04; 106回 SY13-1. ( 医中誌 )

  16. 早稲田 悠馬, 横山 みなと, 安田 庸輔, 上原 翔, 田中 一, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 腎尿管全摘除後の長期的腎機能推移と高度腎機能低下のリスク因子 日本泌尿器科学会総会. 2018.04; 106回 OP-601. ( 医中誌 )

  17. 齋藤 一隆, 安田 庸輔, 伊藤 将也, 田中 一, 木島 俊樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 木原 和徳, 藤井 靖久: C反応性蛋白(CRP)はエンザルタミドを投与した去勢抵抗性前立腺癌症例における全生存に対する予後因子である 日本泌尿器科学会総会. 2018.04; 106回 OP-148. ( 医中誌 )

  1. 上原 翔, 吉田 宗一郎, 松岡 陽, 藤井 靖久: ヘッドマウントディスプレイ補助下MRI-US弾性融合前立腺生検システム 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.12; 9 (2): 42-43. ( 医中誌 )

  2. 吉田 宗一郎, 木原 和徳, 藤井 靖久: 視線操作機能搭載型ヘッドマウントディスプレイ　視線を用いた非接触型user interfaceによる表示画像変換 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.12; 9 (2): 40. ( 医中誌 )

  3. 木島 敏樹, 齋藤 一隆, 上原 翔, 安田 庸輔, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 木原 和徳, 藤井 靖久: ガスレス・シングルポート・ロボサージャン膀胱全摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.12; 9 (2): 64-65. ( 医中誌 )

  4. 井上 雅晴, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: ミニマム創内視鏡下清潔手術における予防的抗菌薬無投与 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.12; 9 (2): 38-39. ( 医中誌 )

  5. 田中 一, 藤井 靖久: 【腎がん診療のパラダイムシフト-診断・治療法の将来像-】 腎細胞がんに対する生検 腎臓内科・泌尿器科. 2017.12; 6 (6): 457-461. ( 医中誌 )

  6. 横山 みなと, 田中 一, 井上 雅晴, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: ガスレス・シングルポート・ロボサージャン腎部分切除　治療選択、合併症対策について 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.12; 9 (2): 18-19. ( 医中誌 )

  7. 藤井 靖久, 木原 和徳, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆: 筋層浸潤膀胱癌に対する膀胱温存療法　ガスレス・シングルポート・ロボサージャン(先端型ミニマム創内視鏡下)膀胱部分切除を組み込んだTMDUプロトコール 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.12; 9 (2): 66-68. ( 医中誌 )

  8. 田中 一, 藤井 靖久: 【腎がん診療のパラダイムシフト-診断・治療法の将来像-】腎細胞がんに対する生検 腎臓内科・泌尿器科. 2017.12; 6 (6): 457-461. ( 医中誌 )

  9. 横山 みなと, 田中 一, 井上 雅晴, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: ガスレス・シングルポート・ロボサージャン腎部分切除　治療選択、合併症対策について 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.12; 9 (2): 18-19. ( 医中誌 )

  10. 齋藤 一隆, 松岡 陽, 田中 一, 木原 和徳, 藤井 靖久: 【新腎・泌尿器癌(下)-基礎・臨床研究の進歩-】 膀胱癌　筋層浸潤膀胱癌に対する、低用量化学放射線療法および膀胱部分切除による膀胱温存療法 日本臨床. 2017.10; 75 (増刊7 新腎・泌尿器癌(下)): 338-343. ( 医中誌 )

  11. 齋藤 一隆, 松岡 陽, 田中 一, 木原 和徳, 藤井 靖久: 【新腎・泌尿器癌(下)-基礎・臨床研究の進歩-】膀胱癌　筋層浸潤膀胱癌に対する、低用量化学放射線療法および膀胱部分切除による膀胱温存療法 日本臨床. 2017.10; 75 (増刊7 新腎・泌尿器癌(下)): 338-343. ( 医中誌 )

  12. 田中 一: 【みんなのがんサポート】身近ながんサポート　食事療法 Modern Physician. 2017.10; 37 (10): 1036-1039. ( 医中誌 )

  13. 石岡 淳一郎, 田中 一, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 3D-HMD・ガスレス・シングルポート腎尿管全摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.08; 9 (1): 101-103. ( 医中誌 )

  14. 吉田 宗一郎, 福与 恒雄, 井上 雅晴, 伊藤 将也, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 術者の視覚運動協応の向上を目的とした内視鏡映像回転調節機能 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.08; 9 (1): 97-100. ( 医中誌 )

  15. 横山 みなと, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: コイン創から行うガスレス・シングルポート・ロボサージャン副腎摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.08; 9 (1): 85-89. ( 医中誌 )

  16. 松岡 陽, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 齋藤 一隆, 木原 和徳, 藤井 靖久: ガスレス・シングルポート・ロボサージャン前立腺全摘除の定型化 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.08; 9 (1): 39-44. ( 医中誌 )

  17. 藤井 靖久, 木原 和徳, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆: 膀胱内外アプローチによるハイブリッド・テクニック(Retroperitoneoscopy and Endoscopy Cooperative Surgery:RECS)を用いたガスレス・シングルポート・ロボサージャン(先端型ミニマム創内視鏡下)膀胱部分切除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.08; 9 (1): 45-50. ( 医中誌 )

  18. 横山 みなと, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: コイン創から行うガスレス・シングルポート・ロボサージャン副腎摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.08; 9 (1): 85-89. ( 医中誌 )

  19. 松岡 陽, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 齋藤 一隆, 木原 和徳, 藤井 靖久: ガスレス・シングルポート・ロボサージャン前立腺全摘除の定型化 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.08; 9 (1): 39-44. ( 医中誌 )

  20. 石岡 淳一郎, 田中 一, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 3D-HMD・ガスレス・シングルポート腎尿管全摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2017.08; 9 (1): 101-103. ( 医中誌 )

  21. 吉田 宗一郎, 藤井 靖久: 【遺伝性がんはここまで解明された】 遺伝性乳頭状腎細胞がんにおける最近の知見 成人病と生活習慣病. 2017.07; 47 (7): 877-880. ( 医中誌 )

  22. 田中 一, 藤井 靖久, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳: 無阻血無縫合腎部分切除後に仮性動脈瘤は発生するか　術後早期造影CTを用いた検討 腎癌研究会会報. 2017.07; (47): 40. ( 医中誌 )

  23. 井上 雅晴, 藤井 靖久, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳: 腎腫瘍に対する腎部分切除後の高血圧発症・増悪およびそのリスク因子 腎癌研究会会報. 2017.07; (47): 27. ( 医中誌 )

  24. 吉田 宗一郎, 藤井 靖久: 【遺伝性がんはここまで解明された】遺伝性乳頭状腎細胞がんにおける最近の知見 成人病と生活習慣病. 2017.07; 47 (7): 877-880. ( 医中誌 )

  25. 田中 一, 藤井 靖久, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳: 無阻血無縫合腎部分切除後に仮性動脈瘤は発生するか　術後早期造影CTを用いた検討 腎癌研究会会報. 2017.07; (47): 40. ( 医中誌 )

  26. 吉田 宗一郎, 高原 太郎, 藤井 靖久: 【MRI最前線】 骨転移の画像診断　DWIBS法を用いた全身拡散強調像 臨床画像. 2017.06; 33 (6): 694-705. ( 医中誌 )

  27. 吉田 宗一郎, 高原 太郎, 藤井 靖久: 【MRI最前線】骨転移の画像診断　DWIBS法を用いた全身拡散強調像 臨床画像. 2017.06; 33 (6): 694-705. ( 医中誌 )

  28. 泉 敬太, 伊藤 将也, 井上 雅晴, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久, 木原 和徳: 脳性ナトリウム利尿ペプチド(BNP)と夜間排尿回数との関連 泌尿器外科. 2017.05; 30 (臨増): 932. ( 医中誌 )

  29. 中山 貴之, 中嶋 裕理, 齋藤 一隆, 井上 雅晴, 伊藤 将也, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 藤井 靖久, 木原 和徳: C-reactive proteinは淡明腎細胞癌の腫瘍増殖能を反映する 泌尿器外科. 2017.05; 30 (臨増): 886. ( 医中誌 )

  30. 中村 祐基, 吉田 宗一郎, 田中 宏, 井上 雅晴, 伊藤 将也, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久, 木原 和徳: 腎腫瘍を中心とした多断面再構成画像による術前評価モデル　腎部分切除における尿路開放の予測 泌尿器外科. 2017.05; 30 (臨増): 887. ( 医中誌 )

  31. 中村 祐基, 田中 一, 藤井 靖久, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳: 筋層浸潤膀胱癌に対する低用量化学放射線療法+膀胱部分切除による膀胱温存療法　高frailty index例に対する治療成績 日本泌尿器科学会総会. 2017.04; 105回 OP13-OP14. ( 医中誌 )

  32. 伊藤 将也, 井上 雅晴, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 沼尾 昇, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 前立腺癌に対するアンドロゲン除去療法は、左心機能マーカー(Brain-type natriuretic peptide:BNP)を上昇させる 日本泌尿器科学会総会. 2017.04; 105回 OP35-OP36. ( 医中誌 )

  33. 伊藤 将也, 泉 敬太, 井上 雅晴, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: Brain-type natriuretic peptide(BNP)高値は男性夜間頻尿と関連する 日本泌尿器科学会総会. 2017.04; 105回 OP32-OP33. ( 医中誌 )

  34. 吉田 宗一郎, 高原 太郎, 石井 千佳子, 井上 雅晴, 伊藤 将也, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: DWIBS法による全身拡散強調MRIを用いた去勢抵抗性前立腺癌の予後評価 日本泌尿器科学会総会. 2017.04; 105回 OP25. ( 医中誌 )

  35. 川村 尚子, 横山 みなと, 中山 貴之, 田中 一, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 無阻血腎部分切除後の急性腎障害　発生率と術後腎機能への影響 日本泌尿器科学会総会. 2017.04; 105回 OP18-OP12. ( 医中誌 )

  36. 中村 祐基, 田中 一, 藤井 靖久, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳: 筋層浸潤膀胱癌に対する低用量化学放射線療法+膀胱部分切除による膀胱温存療法　尿路上皮癌特殊型に対する治療成績 日本泌尿器科学会総会. 2017.04; 105回 OP13-OP15. ( 医中誌 )

  37. 中村 祐基, 田中 一, 藤井 靖久, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳: 筋層浸潤膀胱癌に対する低用量化学放射線療法+膀胱部分切除による膀胱温存療法　尿路上皮癌特殊型に対する治療成績 日本泌尿器科学会総会. 2017.04; 105回 OP13-5. ( 医中誌 )

  38. 中村 祐基, 田中 一, 藤井 靖久, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳: 筋層浸潤膀胱癌に対する低用量化学放射線療法+膀胱部分切除による膀胱温存療法　高frailty index例に対する治療成績 日本泌尿器科学会総会. 2017.04; 105回 OP13-4. ( 医中誌 )

  39. 川村 尚子, 横山 みなと, 中山 貴之, 田中 一, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 無阻血腎部分切除後の急性腎障害　発生率と術後腎機能への影響 日本泌尿器科学会総会. 2017.04; 105回 OP18-2. ( 医中誌 )

  40. 藤井 靖久, 木原 和徳, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆: 膀胱内外アプローチによるハイブリッド・テクニック(Retroperitoneoscopy and Endoscopy Cooperative Surgery;RECS)を用いたガスレス・シングルポート・ロボサージャン(先端型ミニマム創内視鏡下)膀胱部分切除 泌尿器外科. 2017.03; 30 (3): 365-366. ( 医中誌 )

  41. 吉田 宗一郎, 福与 恒雄, 井上 雅晴, 伊藤 将也, 木島 敏樹, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 腎・膀胱・前立腺・その他 術者の視覚運動協応の向上を目的とした内視鏡映像回転調節機能　ミニマム創内視鏡下根治的腎摘除への臨床応用 泌尿器外科. 2017.03; 30 (3): 349. ( 医中誌 )

  42. 松岡 陽, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 齋藤 一隆, 木原 和徳, 藤井 靖久: ガスレス・シングルポート・ロボサージャン前立腺全摘除の定型化 泌尿器外科. 2017.03; 30 (3): 360. ( 医中誌 )

  43. 横山 みなと, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久: 腎・膀胱・前立腺・その他 コイン創から行うガスレス・シングルポート・ロボサージャン副腎摘除 泌尿器外科. 2017.03; 30 (3): 348. ( 医中誌 )

  44. 吉田 宗一郎, 高原 太郎, 藤井 靖久: 【泌尿器科における最新の画像診断と画像支援治療】 DWIBS法(ドゥイブス法)を用いた全身拡散強調MRI　概要と泌尿器癌への応用 泌尿器外科. 2017.03; 30 (3): 263-270. ( 医中誌 )

  45. 吉田 宗一郎, 高原 太郎, 藤井 靖久: 【泌尿器科における最新の画像診断と画像支援治療】DWIBS法(ドゥイブス法)を用いた全身拡散強調MRI　概要と泌尿器癌への応用 泌尿器外科. 2017.03; 30 (3): 263-270. ( 医中誌 )

  46. 吉田　宗一郎、藤井　靖久: DWIBS法(ドゥイブス法)を用いた全身拡散強調MRI-概要と泌尿器癌への応用ー 泌尿器外科. 2017.03;

  1. 田中 一, 藤井 靖久: 【まるごと　膀胱がん】 膀胱がんのdiagnostics　膀胱がんについて患者さんに説明しよう! Uro-Lo: 泌尿器Care & Cure. 2016.08; 21 (4): 473-476. ( 医中誌 )

  2. 中山 貴之, 齋藤 一隆, 藤井 靖久, 井上 雅晴, 伊藤 将也, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 松岡 陽, 木原 和徳: 腎細胞癌におけるM2マクロファージ浸潤はC-reactive proteinと相関する 腎癌研究会会報. 2016.07; (46): 29. ( 医中誌 )

  3. 田中 一, 藤井 靖久, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 沼尾 昇, 齋藤 一隆, 上原 翔, 湯浅 健, 山本 真也, 増田 均, 米瀬 淳二, 木原 和徳: 小径腎腫瘍における脂肪成分の少ない腎血管筋脂肪腫の診断アルゴリスム作成 腎癌研究会会報. 2016.07; (46): 30. ( 医中誌 )

  4. 松岡　陽、井上雅晴、伊藤将也、吉田宗一郎、横山みなと、石岡淳一郎、沼尾　昇、齋藤一隆、藤井靖久、木原和徳: 内視鏡操作ロボットを用いたガスレス・シングルポート・ロボサージャン前立腺全摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2016.07; 8 (1): 31-35.

  1. 佐々木 麻美, 吉田 宗一郎, 佐藤 千景, 山崎 睦子, 高安 純也, 岡林 紀恵, 平野 博美, 横山 みなと, 齋藤 一隆, 藤井 靖久, 木原 和徳: 透過型ヘッドマウントディスプレイを使用した器械出し看護師の補助システム 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2015.07; 7 (1): 55-60. ( 医中誌 )

  2. 中山 貴之, 横山 みなと, 伊藤 将也, 田所 学, 吉田 宗一郎, 石岡 淳一郎, 松岡 陽, 沼尾 昇, 齋藤 一隆, 藤井 靖久, 木原 和徳: ガスレス・シングルポート・ロボサージャン手術の術者教育 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2015.07; 7 (1): 49-53. ( 医中誌 )

  3. 吉田 宗一郎, 伊藤 将也, 田所 学, 横山 みなと, 石岡 淳一郎, 松岡 陽, 沼尾 昇, 齋藤 一隆, 藤井 靖久, 木原 和徳: Head-mounted displayのさまざまな臨床応用 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2015.07; 7 (1): 39-44. ( 医中誌 )

  4. 石岡 淳一郎, 吉田 宗一郎, 伊藤 将也, 田所 学, 横山 みなと, 松岡 陽, 沼尾 昇, 齋藤 一隆, 藤井 靖久, 木原 和徳: ヘッドマウントディスプレイシステムのミニマム創内視鏡下手術以外の、手術、検査への応用 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2015.07; 7 (1): 35-37. ( 医中誌 )

  5. 沼尾 昇, 伊藤 将也, 田所 学, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 藤井 靖久, 木原 和徳: ガスレス・シングルポート・ロボサージャン(先端型ミニマム創内視鏡下)前立腺全摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2015.07; 7 (1): 29-34. ( 医中誌 )

  6. 中村 祐基, 吉田 宗一郎, 森山 真吾, 中山 貴之, 井上 雅晴, 伊藤 将也, 田所 学, 横山 みなと, 石岡 淳一郎, 松岡 陽, 沼尾 昇, 齋藤 一隆, 藤井 靖久, 木原 和徳: TURBTの術後変化と残存浸潤癌との鑑別に拡散強調MRIが有用であった1例 泌尿器外科. 2015.06; 28 (6): 1113-1116. ( 医中誌 )

  1. 齋藤 一隆, 竹下 英毅, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 沼尾 昇, 古賀 文隆, 増田 均, 藤井 靖久, 木原 和徳: 3D-HMD・ガスレス・シングルポート腎尿管全摘除/根治的腎摘除 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2013.07; 5 (1): 87-91. ( 医中誌 )

  2. 竹下 英毅, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 沼尾 昇, 齋藤 一隆, 古賀 文隆, 増田 均, 藤井 靖久, 木原 和徳: 3D-HMD・ガスレス・シングルポート・無阻血腎部分切除　卒後9年の医師の経験 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2013.07; 5 (1): 97-101. ( 医中誌 )

  3. 木島 敏樹, 増田 均, 田所 学, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 沼尾 昇, 齋藤 一隆, 古賀 文隆, 藤井 靖久, 木原 和徳: ミニマム創内視鏡下手術における抗菌薬非投与　抗菌薬段階的減量試験およびMRSA検出率経時的調査 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2013.07; 5 (1): 103-106. ( 医中誌 )

  4. 石岡 淳一郎, 吉田 宗一郎, 横山 みなと, 松岡 陽, 沼尾 昇, 齋藤 一隆, 古賀 文隆, 増田 均, 藤井 靖久, 木原 和徳: ミニマム創内視鏡下手術に役立つ器具の紹介 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2013.07; 5 (1): 111-112. ( 医中誌 )

  5. 横山 みなと, 藤井 靖久, 吉田 宗一郎, 石岡 淳一郎, 沼尾 昇, 松岡 陽, 古賀 文隆, 齋藤 一隆, 増田 均, 木原 和徳: ミニマム創内視鏡下(ガスレス・シングルポート)無阻血腎部分切除後の腎機能の検討　Tumor complexityは術後腎機能に影響を与えるか? 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2013.07; 5 (1): 119-123. ( 医中誌 )

  6. 竹下 英毅, 木原 和徳, 中西 泰一, 木島 敏樹, 吉田 宗一郎, 横山 みなと, 石岡 淳一郎, 松岡 陽, 沼尾 昇, 齋藤 一隆, 古賀 文隆, 藤井 靖久: 3Dヘッドマウント・ディスプレイシステムの3D内視鏡外科手術における有用性の検討　術者、助手、スコピスト別の評価 日本ミニマム創泌尿器内視鏡外科学会雑誌. 2013.07; 5 (1): 165-171. ( 医中誌 )

  7. 森山 真吾, 吉田 宗一郎, 竹下 英毅, 倉田 盛人, 岡田 洋平, 斎藤 一隆, 古賀 文隆, 増田 均, 藤井 靖久, 川上 理, 木原 和徳: 拡散強調MR画像にて高信号を呈した膀胱炎症性病変の1例　組織学的所見との比較による考察 日本泌尿器科学会雑誌. 2013.05; 104 (3): 545-548. ( PubMed )

  8. 砂倉 瑞明, 藤井 靖久, 増田 均, 上原 翔, 秋山 佳之, 助川 玄, 田中 一, 吉川 慎一, 浦上 慎司, 湯浅 健, 山本 真也, 米瀬 淳二, 福井 巖: 腹腔鏡下小切開腎部分切除における綿状コラーゲン製止血材の初期使用経験 Pharma Medica. 2013.03; 31 (3): 207-209.

  1. 加瀬 浩史, 荒木 重人, 北村 唯一, 小山 康弘, 井之輪 俊彦, 石丸 尚, 各務 裕, 吉田 宗一郎, 嘉村 康邦: 実地診療下における過活動膀胱に対する各種抗コリン薬の有効性および口内乾燥に関する比較検討 泌尿器外科. 2010.09; 23 (9): 1299-1306. ( 医中誌 )

  2. 川上 理, 吉田 宗一郎: 【血尿の画像診断　何を疑ってどう攻めるか?】 尿路腫瘍診断　血尿と尿路腫瘍 臨床画像. 2010.06; 26 (6): 608-619. ( 医中誌 )

  3. 吉田 宗一郎, 増田 均: 【腎・泌尿器癌　基礎・臨床研究のアップデート】 膀胱癌　臨床研究　診断と分類　画像診断 日本臨床. 2010.04; 68 (増刊4 腎・泌尿器癌): 245-248. ( 医中誌 )

  4. 田所 学, 増田 均, 吉田 宗一郎, 砂倉 瑞明, 木原 和徳: 泌尿器科領域における手術部位感染 泌尿器科領域における術後感染対策III　ミニマム創内視鏡下手術における手術部位感染対策 臨床泌尿器科. 2010.02; 64 (2): 137-142. ( 医中誌 )

  1. 田中 一, 増田 均, 駒井 好信, 横山 みなと, 岩井 安芸, 沼尾 昇, 酒井 康之, 斉藤 一隆, 藤井 靖久, 小林 剛, 川上 理, 木原 和徳: 集学的治療を施行した原発性女子尿道腺癌の1例 泌尿器科紀要. 2009.01; 55 (1): 43-46. ( PubMed )

  1. 中山 貴之, 吉田 宗一郎, 藤井 靖久, 古賀 文隆, 齋藤 一隆, 増田 均, 小林 剛, 川上 理, 木原 和徳: 膀胱癌リンパ節転移に対するMRI拡散強調画像の使用経験　化学療法効果判定における可能性について 日本泌尿器科学会雑誌. 2008.11; 99 (7): 737-741. ( 医中誌 )

  2. 中山貴之、吉田宗一郎、藤井靖久ら: 膀胱癌リンパ節転移に対するMRI拡散強調画像の使用経験 -化学療法効果判定における可能性について- 日本泌尿器外科学会雑誌. 2008.11; 99 (7): 737-741. ( PubMed )

  3. 田中 一, 沼尾 昇, 川上 理, 駒井 好信, 田所 学, 吉田 宗一郎, 砂倉 瑞明, 横山 みなと, 飯村 康正, 岩井 安芸, 酒井 康之, 古賀 文隆, 斉藤 一隆, 一柳 暢孝, 藤井 靖久, 小林 剛, 木原 和徳: ホルモン抵抗性前立腺癌に対するdocetaxel療法の検討 泌尿器外科. 2008.08; 21 (８): 1111-1114.

  4. 田中 一, 沼尾 昇, 川上 理, 駒井 好信, 田所 学, 吉田 宗一郎, 砂倉 瑞明, 横山 みなと, 飯村 康正, 岩井 安芸, 酒井 康之, 古賀 文隆, 斉藤 一隆, 一柳 暢孝, 藤井 靖久, 小林 剛, 木原 和徳: ホルモン抵抗性前立腺癌に対するdocetaxel療法の検討 泌尿器外科. 2008.08; 21 (8): 1111-1114. ( 医中誌 )

  5. 吉田 宗一郎, 木原 和徳: 【腎機能と画像診断】 血尿の腎画像診断の考え方 成人病と生活習慣病. 2008.07; 38 (7): 803-808. ( 医中誌 )

  1. 酒井 康之, 増田 均, 吉田 宗一郎, 横山 みなと, 砂倉 瑞明, 田中 将樹, 飯村 康正, 松岡 陽, 沼尾 昇, 斉藤 一隆, 古賀 文隆, 小林 剛, 川上 理, 木原 和徳: ミニマム創内視鏡下泌尿器手術(前立腺全摘除・根治的腎摘除)の患者満足度調査 泌尿器外科. 2007.12; 20 (12): 1559-1565. ( 医中誌 )

  2. 吉永 敦史, 吉田 宗一郎, 中込 一彰, 後藤 修一: 導尿目的で利用したネギによる膀胱尿道異物の1例 日本泌尿器科学会雑誌. 2007.07; 98 (5): 710-712. ( PubMed )

  3. 田中 一, 野口 典男, 藍原 有弘, 入江 工, 落合 高徳, 工藤 篤, 中村 典明, 伊東 浩次, 田中 真二, 川村 徹, 寺本 研一, 有井 滋樹: 術前診断が困難であった多発性肝毛細血管性血管腫の1例 Liver Cancer. 2007.05; 13 (1): 51-58.

  4. 吉永 敦史, 諸角 誠人, 石井 信行, 吉田 宗一郎, 大野 玲奈, 寺尾 俊哉, 林 哲夫, 山田 拓己: 馬蹄鉄腎に合併した腎細胞癌および腎結石の1例 泌尿器外科. 2007.02; 20 (2): 151-153. ( 医中誌 )

  5. 吉永 敦史, 諸角 誠人, 吉田 宗一郎, 大野 玲奈, 石井 信行, 寺尾 俊哉, 鎌田 成芳, 林 哲夫, 山田 拓己: 2動原体性Y染色体を呈した尿道下裂の1例 日本泌尿器科学会雑誌. 2007.01; 98 (1): 30-33. ( PubMed )

  1. 吉永 敦史, 林 哲夫, 吉田 宗一郎, 大野 玲奈, 石井 信行, 寺尾 俊哉, 諸角 誠人, 山田 拓己: 陰茎折症の6例 泌尿器外科. 2006.10; 19 (10): 1245-1248. ( 医中誌 )

  2. 駒井 好信, 川上 理, 吉田 宗一郎, 酒井 康之, 小林 剛, 影山 幸雄, 木原 和徳: 巨大な後腹膜腫瘍を呈した嚢胞形成を伴う副腎節神経腫の1例 泌尿器科紀要. 2006.07; 52 (7): 549-551. ( 医中誌 )

  3. 駒井好信、川上理、吉田宗一郎、酒井康之、小林剛、影山幸雄、木原和徳: 巨大な後腹膜腫瘍を呈した嚢胞形成を伴う副腎節神経腫の1例 泌尿器科紀要. 2006.07; 52 (7): 549-551. ( PubMed )

  4. 吉永敦史、林 哲夫、吉田 宗一郎、大野 玲奈、石井 信行、寺尾 俊哉、渡邉 徹、山田 拓己 : 泌尿器科悪性腫瘍患者における併存疾患の有病率の比較・検討 泌尿器科紀要. 2006.07; 52 (7): 537-541. ( PubMed )

  5. 石井信行、吉田宗一郎、吉永敦史、大野 玲奈、寺尾 俊哉、渡邉 徹、林哲夫、山田 拓己 : 緩徐な経過を示した精索原発平滑筋肉腫の1例 Hinyokika Kiyo. 2006.02; 52 (2): 159-161. ( PubMed )

  6. 大野 玲奈, 林 哲夫, 吉田 宗一郎, 吉永 敦史, 石井 信行, 寺尾 俊哉, 渡邉 徹, 山田 拓己: 腹圧性尿失禁手術中に発症した肺血栓塞栓症の1例 泌尿器外科. 2006.01; 19 (1): 47-50. ( 医中誌 )

  7. 吉田宗一郎、渡邉 徹、吉永敦史、大野 玲奈、石井信行、寺尾 俊哉、林哲夫、山田 拓己 : 腎盂に発生した炎症性筋線維芽細胞性腫瘍の1例 泌尿器科紀要. 2006.01; 52 (1): 31-33. ( PubMed )

  1. 吉田 宗一郎, 林 哲夫, 吉永 敦史, 大野 玲奈, 石井 信行, 寺尾 俊哉, 渡邉 徹, 山田 拓己: hCG-β高値を呈した転移性精索腫瘍の1例 日本泌尿器科学会雑誌. 2005.11; 96 (7): 714-716. ( PubMed )

  2. 吉田宗一郎、林哲夫、吉永敦史、大野 玲奈、石井信行、寺尾 俊哉、渡邉 徹、山田 拓己 : 膀胱癌に対する膀胱全摘出術後の経過観察指針についての検討 泌尿器科紀要. 2005.11; 51 (11): 727-730. ( PubMed )

  3. 吉永 敦史, 林 哲夫, 吉田 宗一郎, 大野 玲奈, 石井 信行, 山田 拓己: 犬咬傷による右陰嚢内容脱出 臨床泌尿器科. 2005.09; 59 (10): 780-781. ( 医中誌 )

  4. 吉田 宗一郎, 宮田 和豊, 青木 茂弘: 精索に発生した炎症性偽腫瘍 臨床泌尿器科. 2005.09; 59 (10): 771-773. ( 医中誌 )

  5. 吉永敦史、林哲夫、大野 玲奈、吉田宗一郎、石井信行、寺尾 俊哉、渡邉 徹、山田 拓己 : 特発性血小板減少性紫斑病を合併した腎細胞癌の1例 泌尿器科紀要. 2005.06; 51 (6): 377-380. ( PubMed )

  6. 吉永敦史、林哲夫、石井信行、吉田宗一郎、大野 玲奈、寺尾 俊哉、渡邉 徹、山田 拓己 : 診断に難渋した感染性腎嚢胞自然破裂の1例 泌尿器科紀要. 2005.04; 51 (4): 257-259. ( PubMed )

  7. 吉永 敦史, 林 哲夫, 吉田 宗一郎, 大野 玲奈, 石井 信行, 寺尾 俊哉, 渡邉 徹, 山田 拓己: 膀胱タンポナーデの臨床的検討 臨床泌尿器科. 2005.03; 59 (3): 225-227. ( 医中誌 )

  8. 吉田 宗一郎, 中込 一彰, 後藤 修一: 真性尿管憩室の1例 日本泌尿器科学会雑誌. 2005.01; 96 (1): 25-28. ( PubMed )

  1. 吉田 宗一郎, 中込 一彰, 後藤 修一: 画像診断　イレウス症状を呈した気腫性膀胱炎 臨床泌尿器科. 2004.12; 58 (13): 1054-1055. ( 医中誌 )

  2. 吉田 宗一郎, 兵地 信彦, 駒井 好信, 田所 学, 増田 均, 川上 理, 藤井 靖久, 小林 剛, 影山 幸雄, 木原 和徳: 単一小切開(ミニマム創)内視鏡下生検にて術前に確定診断し得た下大静脈原発平滑筋肉腫の1例 泌尿器外科. 2004.10; 17 (10): 1105-1109. ( 医中誌 )

  3. 吉田 宗一郎, 川上 理, 駒井 好信, 田所 学, 横山 みなと, 斉藤 一隆, 影山 幸雄, 木原 和徳: 精索原発平滑筋肉腫の1例 日本泌尿器外科学会雑誌. 2004.07; 95 (5): 718-721. ( PubMed )

  4. 吉田 宗一郎, 中込 一彰, 後藤 修一: 急性腎盂腎炎入院例の臨床的検討　複雑性腎盂腎炎,結石性腎盂腎炎を中心に 臨床泌尿器科. 2004.05; 58 (6): 423-426. ( 医中誌 )

  1. 駒井 好信, 藤井 靖久, 吉田 宗一郎, 鈴木 常貴, 齋藤 一隆, 小林 剛, 影山 幸雄, 木原 和徳: 術前診断が困難であった尿管子宮内膜症の1例 泌尿器外科. 2003.08; 16 (8): 883-886. ( 医中誌 )

このページの先頭へ▲